id	sid	tid	token	lemma	pos
ajlm-786	1	1	abstract	abstract	ADJ
ajlm-786	1	2	introduction	introduction	NOUN
ajlm-786	1	3	methods	method	NOUN
ajlm-786	1	4	results	result	VERB
ajlm-786	1	5	discussion	discussion	NOUN
ajlm-786	1	6	acknowledgements	acknowledgement	NOUN
ajlm-786	1	7	references	reference	NOUN
ajlm-786	1	8	about	about	ADP
ajlm-786	1	9	the	the	DET
ajlm-786	1	10	author(s	author(s	NOUN
ajlm-786	1	11	)	)	PUNCT
ajlm-786	1	12	ellen	ellen	PROPN
ajlm-786	1	13	gobusamang	gobusamang	PROPN
ajlm-786	1	14	department	department	PROPN
ajlm-786	1	15	of	of	ADP
ajlm-786	1	16	medical	medical	PROPN
ajlm-786	1	17	laboratory	laboratory	NOUN
ajlm-786	1	18	sciences	sciences	PROPN
ajlm-786	1	19	,	,	PUNCT
ajlm-786	1	20	faculty	faculty	NOUN
ajlm-786	1	21	of	of	ADP
ajlm-786	1	22	health	health	NOUN
ajlm-786	1	23	sciences	sciences	PROPN
ajlm-786	1	24	,	,	PUNCT
ajlm-786	1	25	university	university	PROPN
ajlm-786	1	26	of	of	ADP
ajlm-786	1	27	botswana	botswana	PROPN
ajlm-786	1	28	,	,	PUNCT
ajlm-786	1	29	gaborone	gaborone	PROPN
ajlm-786	1	30	,	,	PUNCT
ajlm-786	1	31	botswana	botswana	PROPN
ajlm-786	1	32	naledi	naledi	PROPN
ajlm-786	1	33	g.	g.	PROPN
ajlm-786	1	34	nyepetsi	nyepetsi	PROPN
ajlm-786	1	35	department	department	PROPN
ajlm-786	1	36	of	of	ADP
ajlm-786	1	37	medical	medical	PROPN
ajlm-786	1	38	laboratory	laboratory	NOUN
ajlm-786	1	39	sciences	sciences	PROPN
ajlm-786	1	40	,	,	PUNCT
ajlm-786	1	41	faculty	faculty	NOUN
ajlm-786	1	42	of	of	ADP
ajlm-786	1	43	health	health	NOUN
ajlm-786	1	44	sciences	sciences	PROPN
ajlm-786	1	45	,	,	PUNCT
ajlm-786	1	46	university	university	PROPN
ajlm-786	1	47	of	of	ADP
ajlm-786	1	48	botswana	botswana	PROPN
ajlm-786	1	49	,	,	PUNCT
ajlm-786	1	50	gaborone	gaborone	PROPN
ajlm-786	1	51	,	,	PUNCT
ajlm-786	1	52	botswana	botswana	PROPN
ajlm-786	1	53	modisa	modisa	PROPN
ajlm-786	1	54	s.	s.	PROPN
ajlm-786	1	55	motswaledi	motswaledi	PROPN
ajlm-786	1	56	department	department	PROPN
ajlm-786	1	57	of	of	ADP
ajlm-786	1	58	medical	medical	PROPN
ajlm-786	1	59	laboratory	laboratory	NOUN
ajlm-786	1	60	sciences	sciences	PROPN
ajlm-786	1	61	,	,	PUNCT
ajlm-786	1	62	faculty	faculty	NOUN
ajlm-786	1	63	of	of	ADP
ajlm-786	1	64	health	health	NOUN
ajlm-786	1	65	sciences	sciences	PROPN
ajlm-786	1	66	,	,	PUNCT
ajlm-786	1	67	university	university	PROPN
ajlm-786	1	68	of	of	ADP
ajlm-786	1	69	botswana	botswana	PROPN
ajlm-786	1	70	,	,	PUNCT
ajlm-786	1	71	gaborone	gaborone	PROPN
ajlm-786	1	72	,	,	PUNCT
ajlm-786	1	73	botswana	botswana	PROPN
ajlm-786	1	74	ishmael	ishmael	PROPN
ajlm-786	1	75	kasvosve	kasvosve	PROPN
ajlm-786	1	76	department	department	PROPN
ajlm-786	1	77	of	of	ADP
ajlm-786	1	78	medical	medical	PROPN
ajlm-786	1	79	laboratory	laboratory	NOUN
ajlm-786	1	80	sciences	sciences	PROPN
ajlm-786	1	81	,	,	PUNCT
ajlm-786	1	82	faculty	faculty	NOUN
ajlm-786	1	83	of	of	ADP
ajlm-786	1	84	health	health	NOUN
ajlm-786	1	85	sciences	sciences	PROPN
ajlm-786	1	86	,	,	PUNCT
ajlm-786	1	87	university	university	PROPN
ajlm-786	1	88	of	of	ADP
ajlm-786	1	89	botswana	botswana	PROPN
ajlm-786	1	90	,	,	PUNCT
ajlm-786	1	91	gaborone	gaborone	PROPN
ajlm-786	1	92	,	,	PUNCT
ajlm-786	1	93	botswana	botswana	PROPN
ajlm-786	1	94	citation	citation	PROPN
ajlm-786	1	95	gobusamang	gobusamang	PROPN
ajlm-786	1	96	e	e	PROPN
ajlm-786	1	97	,	,	PUNCT
ajlm-786	1	98	nyepetsi	nyepetsi	PROPN
ajlm-786	1	99	ng	ng	PROPN
ajlm-786	1	100	,	,	PUNCT
ajlm-786	1	101	motswaledi	motswaledi	PROPN
ajlm-786	1	102	ms	ms	PROPN
ajlm-786	1	103	,	,	PUNCT
ajlm-786	1	104	kasvosve	kasvosve	PROPN
ajlm-786	1	105	i.	i.	PROPN
ajlm-786	1	106	hyperuricaemia	hyperuricaemia	PROPN
ajlm-786	1	107	is	be	AUX
ajlm-786	1	108	associated	associate	VERB
ajlm-786	1	109	with	with	ADP
ajlm-786	1	110	dyslipidemia	dyslipidemia	NOUN
ajlm-786	1	111	but	but	CCONJ
ajlm-786	1	112	not	not	PART
ajlm-786	1	113	hba1c	hba1c	PROPN
ajlm-786	1	114	among	among	ADP
ajlm-786	1	115	type	type	NOUN
ajlm-786	1	116	2	2	NUM
ajlm-786	1	117	diabetes	diabetes	NOUN
ajlm-786	1	118	mellitus	mellitus	NOUN
ajlm-786	1	119	patients	patient	NOUN
ajlm-786	1	120	in	in	ADP
ajlm-786	1	121	botswana	botswana	PROPN
ajlm-786	1	122	.	.	PUNCT
ajlm-786	2	1	afr	afr	PROPN
ajlm-786	2	2	j	j	PROPN
ajlm-786	2	3	lab	lab	PROPN
ajlm-786	2	4	med	med	PROPN
ajlm-786	2	5	.	.	PUNCT
ajlm-786	2	6	2019;8(1	2019;8(1	NOUN
ajlm-786	2	7	)	)	PUNCT
ajlm-786	2	8	,	,	PUNCT
ajlm-786	2	9	a786	a786	PROPN
ajlm-786	2	10	.	.	PUNCT
ajlm-786	3	1	https://doi.org/10.4102/ajlm.v8i1.786	https://doi.org/10.4102/ajlm.v8i1.786	PROPN
ajlm-786	3	2	brief	brief	PROPN
ajlm-786	3	3	report	report	NOUN
ajlm-786	3	4	hyperuricaemia	hyperuricaemia	NOUN
ajlm-786	3	5	is	be	AUX
ajlm-786	3	6	associated	associate	VERB
ajlm-786	3	7	with	with	ADP
ajlm-786	3	8	dyslipidemia	dyslipidemia	NOUN
ajlm-786	3	9	but	but	CCONJ
ajlm-786	3	10	not	not	PART
ajlm-786	3	11	hba1c	hba1c	PROPN
ajlm-786	3	12	among	among	ADP
ajlm-786	3	13	type	type	NOUN
ajlm-786	3	14	2	2	NUM
ajlm-786	3	15	diabetes	diabetes	NOUN
ajlm-786	3	16	mellitus	mellitus	NOUN
ajlm-786	3	17	patients	patient	NOUN
ajlm-786	3	18	in	in	ADP
ajlm-786	3	19	botswana	botswana	PROPN
ajlm-786	3	20	ellen	ellen	PROPN
ajlm-786	3	21	gobusamang	gobusamang	PROPN
ajlm-786	3	22	,	,	PUNCT
ajlm-786	3	23	naledi	naledi	PROPN
ajlm-786	3	24	g.	g.	PROPN
ajlm-786	3	25	nyepetsi	nyepetsi	PROPN
ajlm-786	3	26	,	,	PUNCT
ajlm-786	3	27	modisa	modisa	PROPN
ajlm-786	3	28	s.	s.	PROPN
ajlm-786	3	29	motswaledi	motswaledi	PROPN
ajlm-786	3	30	,	,	PUNCT
ajlm-786	3	31	ishmael	ishmael	PROPN
ajlm-786	3	32	kasvosve	kasvosve	PROPN
ajlm-786	3	33	received	receive	VERB
ajlm-786	3	34	:	:	PUNCT
ajlm-786	3	35	07	07	NUM
ajlm-786	3	36	feb	feb	PROPN
ajlm-786	3	37	.	.	PROPN
ajlm-786	3	38	2018	2018	NUM
ajlm-786	3	39	;	;	PUNCT
ajlm-786	3	40	accepted	accept	VERB
ajlm-786	3	41	:	:	PUNCT
ajlm-786	3	42	28	28	NUM
ajlm-786	3	43	june	june	PROPN
ajlm-786	3	44	2019	2019	NUM
ajlm-786	3	45	;	;	PUNCT
ajlm-786	3	46	published	publish	VERB
ajlm-786	3	47	:	:	PUNCT
ajlm-786	3	48	07	07	NUM
ajlm-786	3	49	nov	nov	PROPN
ajlm-786	3	50	.	.	PROPN
ajlm-786	3	51	2019	2019	NUM
ajlm-786	3	52	copyright	copyright	NOUN
ajlm-786	3	53	:	:	PUNCT
ajlm-786	3	54	©	©	PROPN
ajlm-786	3	55	2019	2019	NUM
ajlm-786	3	56	.	.	PUNCT
ajlm-786	4	1	the	the	DET
ajlm-786	4	2	author(s	author(s	PROPN
ajlm-786	4	3	)	)	PUNCT
ajlm-786	4	4	.	.	PUNCT
ajlm-786	5	1	licensee	licensee	NOUN
ajlm-786	5	2	:	:	PUNCT
ajlm-786	5	3	aosis	aosis	NOUN
ajlm-786	5	4	.	.	PUNCT
ajlm-786	6	1	this	this	PRON
ajlm-786	6	2	is	be	AUX
ajlm-786	6	3	an	an	DET
ajlm-786	6	4	open	open	ADJ
ajlm-786	6	5	access	access	NOUN
ajlm-786	6	6	article	article	NOUN
ajlm-786	6	7	distributed	distribute	VERB
ajlm-786	6	8	under	under	ADP
ajlm-786	6	9	the	the	DET
ajlm-786	6	10	terms	term	NOUN
ajlm-786	6	11	of	of	ADP
ajlm-786	6	12	the	the	DET
ajlm-786	6	13	creative	creative	ADJ
ajlm-786	6	14	commons	common	NOUN
ajlm-786	6	15	attribution	attribution	NOUN
ajlm-786	6	16	license	license	NOUN
ajlm-786	6	17	,	,	PUNCT
ajlm-786	6	18	which	which	PRON
ajlm-786	6	19	permits	permit	VERB
ajlm-786	6	20	unrestricted	unrestricted	ADJ
ajlm-786	6	21	use	use	NOUN
ajlm-786	6	22	,	,	PUNCT
ajlm-786	6	23	distribution	distribution	NOUN
ajlm-786	6	24	,	,	PUNCT
ajlm-786	6	25	and	and	CCONJ
ajlm-786	6	26	reproduction	reproduction	NOUN
ajlm-786	6	27	in	in	ADP
ajlm-786	6	28	any	any	DET
ajlm-786	6	29	medium	medium	NOUN
ajlm-786	6	30	,	,	PUNCT
ajlm-786	6	31	provided	provide	VERB
ajlm-786	6	32	the	the	DET
ajlm-786	6	33	original	original	ADJ
ajlm-786	6	34	work	work	NOUN
ajlm-786	6	35	is	be	AUX
ajlm-786	6	36	properly	properly	ADV
ajlm-786	6	37	cited	cite	VERB
ajlm-786	6	38	.	.	PUNCT
ajlm-786	7	1	abstract	abstract	ADJ
ajlm-786	7	2	medical	medical	ADJ
ajlm-786	7	3	records	record	NOUN
ajlm-786	7	4	and	and	CCONJ
ajlm-786	7	5	residual	residual	ADJ
ajlm-786	7	6	samples	sample	NOUN
ajlm-786	7	7	from	from	ADP
ajlm-786	7	8	334	334	NUM
ajlm-786	7	9	type	type	NOUN
ajlm-786	7	10	2	2	NUM
ajlm-786	7	11	diabetes	diabetes	NOUN
ajlm-786	7	12	mellitus	mellitus	NOUN
ajlm-786	7	13	patients	patient	NOUN
ajlm-786	7	14	attending	attend	VERB
ajlm-786	7	15	a	a	DET
ajlm-786	7	16	clinic	clinic	NOUN
ajlm-786	7	17	in	in	ADP
ajlm-786	7	18	gaborone	gaborone	PROPN
ajlm-786	7	19	,	,	PUNCT
ajlm-786	7	20	botswana	botswana	PROPN
ajlm-786	7	21	,	,	PUNCT
ajlm-786	7	22	during	during	ADP
ajlm-786	7	23	the	the	DET
ajlm-786	7	24	period	period	NOUN
ajlm-786	7	25	september	september	PROPN
ajlm-786	7	26	–	–	PUNCT
ajlm-786	7	27	december	december	PROPN
ajlm-786	7	28	2016	2016	NUM
ajlm-786	7	29	were	be	AUX
ajlm-786	7	30	analysed	analyse	VERB
ajlm-786	7	31	for	for	ADP
ajlm-786	7	32	the	the	DET
ajlm-786	7	33	effects	effect	NOUN
ajlm-786	7	34	of	of	ADP
ajlm-786	7	35	hyperuricaemia	hyperuricaemia	NOUN
ajlm-786	7	36	on	on	ADP
ajlm-786	7	37	biochemical	biochemical	ADJ
ajlm-786	7	38	markers	marker	NOUN
ajlm-786	7	39	of	of	ADP
ajlm-786	7	40	adverse	adverse	ADJ
ajlm-786	7	41	outcomes	outcome	NOUN
ajlm-786	7	42	.	.	PUNCT
ajlm-786	8	1	the	the	DET
ajlm-786	8	2	patients	patient	NOUN
ajlm-786	8	3	were	be	AUX
ajlm-786	8	4	stratified	stratify	VERB
ajlm-786	8	5	as	as	ADP
ajlm-786	8	6	having	have	VERB
ajlm-786	8	7	hyperuricaemia	hyperuricaemia	X
ajlm-786	8	8	(	(	PUNCT
ajlm-786	8	9	>	>	X
ajlm-786	8	10	400	400	NUM
ajlm-786	8	11	µmol	µmol	ADP
ajlm-786	8	12	/	/	SYM
ajlm-786	8	13	l	l	NOUN
ajlm-786	8	14	)	)	PUNCT
ajlm-786	8	15	or	or	CCONJ
ajlm-786	8	16	normal	normal	ADJ
ajlm-786	8	17	serum	serum	NOUN
ajlm-786	8	18	uric	uric	ADJ
ajlm-786	8	19	acid	acid	NOUN
ajlm-786	8	20	(	(	PUNCT
ajlm-786	8	21	≤	≤	NOUN
ajlm-786	8	22	400	400	NUM
ajlm-786	8	23	µmol	µmol	NOUN
ajlm-786	8	24	/	/	SYM
ajlm-786	8	25	l	l	NOUN
ajlm-786	8	26	)	)	PUNCT
ajlm-786	8	27	.	.	PUNCT
ajlm-786	9	1	we	we	PRON
ajlm-786	9	2	compared	compare	VERB
ajlm-786	9	3	glycated	glycate	VERB
ajlm-786	9	4	haemoglobin	haemoglobin	NOUN
ajlm-786	9	5	,	,	PUNCT
ajlm-786	9	6	triglycerides	triglyceride	NOUN
ajlm-786	9	7	,	,	PUNCT
ajlm-786	9	8	low	low	ADJ
ajlm-786	9	9	-	-	PUNCT
ajlm-786	9	10	density	density	NOUN
ajlm-786	9	11	lipoprotein	lipoprotein	ADJ
ajlm-786	9	12	-	-	PUNCT
ajlm-786	9	13	cholesterol	cholesterol	NOUN
ajlm-786	9	14	,	,	PUNCT
ajlm-786	9	15	high	high	ADJ
ajlm-786	9	16	-	-	PUNCT
ajlm-786	9	17	density	density	NOUN
ajlm-786	9	18	lipoprotein	lipoprotein	ADJ
ajlm-786	9	19	-	-	PUNCT
ajlm-786	9	20	cholesterol	cholesterol	NOUN
ajlm-786	9	21	,	,	PUNCT
ajlm-786	9	22	total	total	ADJ
ajlm-786	9	23	cholesterol	cholesterol	NOUN
ajlm-786	9	24	and	and	CCONJ
ajlm-786	9	25	serum	serum	NOUN
ajlm-786	9	26	creatinine	creatinine	NOUN
ajlm-786	9	27	between	between	ADP
ajlm-786	9	28	the	the	DET
ajlm-786	9	29	two	two	NUM
ajlm-786	9	30	serum	serum	NOUN
ajlm-786	9	31	uric	uric	ADJ
ajlm-786	9	32	acid	acid	NOUN
ajlm-786	9	33	categories	category	NOUN
ajlm-786	9	34	.	.	PUNCT
ajlm-786	10	1	hyperuricaemia	hyperuricaemia	PROPN
ajlm-786	10	2	was	be	AUX
ajlm-786	10	3	detected	detect	VERB
ajlm-786	10	4	in	in	ADP
ajlm-786	10	5	28	28	NUM
ajlm-786	10	6	%	%	NOUN
ajlm-786	10	7	of	of	ADP
ajlm-786	10	8	patients	patient	NOUN
ajlm-786	10	9	(	(	PUNCT
ajlm-786	10	10	95	95	NUM
ajlm-786	10	11	%	%	NOUN
ajlm-786	10	12	confidence	confidence	NOUN
ajlm-786	10	13	interval	interval	NOUN
ajlm-786	10	14	23.1–32.9	23.1–32.9	NUM
ajlm-786	10	15	)	)	PUNCT
ajlm-786	10	16	and	and	CCONJ
ajlm-786	10	17	was	be	AUX
ajlm-786	10	18	associated	associate	VERB
ajlm-786	10	19	with	with	ADP
ajlm-786	10	20	increased	increase	VERB
ajlm-786	10	21	serum	serum	NOUN
ajlm-786	10	22	triglycerides	triglyceride	NOUN
ajlm-786	10	23	,	,	PUNCT
ajlm-786	10	24	triglyceride	triglyceride	ADP
ajlm-786	10	25	to	to	ADP
ajlm-786	10	26	high	high	ADJ
ajlm-786	10	27	-	-	PUNCT
ajlm-786	10	28	density	density	NOUN
ajlm-786	10	29	lipoprotein	lipoprotein	ADJ
ajlm-786	10	30	-	-	PUNCT
ajlm-786	10	31	cholesterol	cholesterol	NOUN
ajlm-786	10	32	ratio	ratio	NOUN
ajlm-786	10	33	and	and	CCONJ
ajlm-786	10	34	creatinine	creatinine	NOUN
ajlm-786	10	35	concentration	concentration	NOUN
ajlm-786	10	36	,	,	PUNCT
ajlm-786	10	37	but	but	CCONJ
ajlm-786	10	38	not	not	PART
ajlm-786	10	39	with	with	ADP
ajlm-786	10	40	glycated	glycate	VERB
ajlm-786	10	41	haemoglobin	haemoglobin	NOUN
ajlm-786	10	42	.	.	PUNCT
ajlm-786	11	1	keywords	keyword	NOUN
ajlm-786	11	2	:	:	PUNCT
ajlm-786	11	3	hyperuricaemia	hyperuricaemia	VERB
ajlm-786	11	4	;	;	PUNCT
ajlm-786	11	5	diabetes	diabetes	NOUN
ajlm-786	11	6	mellitus	mellitus	NOUN
ajlm-786	11	7	;	;	PUNCT
ajlm-786	11	8	glycated	glycate	VERB
ajlm-786	11	9	haemoglobin	haemoglobin	NOUN
ajlm-786	11	10	;	;	PUNCT
ajlm-786	11	11	lipids	lipid	NOUN
ajlm-786	11	12	;	;	PUNCT
ajlm-786	11	13	africans	africans	PROPN
ajlm-786	11	14	.	.	PUNCT
ajlm-786	12	1	introduction	introduction	NOUN
ajlm-786	12	2	epidemiologic	epidemiologic	ADJ
ajlm-786	12	3	studies	study	NOUN
ajlm-786	12	4	suggest	suggest	VERB
ajlm-786	12	5	that	that	SCONJ
ajlm-786	12	6	hyperuricaemia	hyperuricaemia	NOUN
ajlm-786	12	7	plays	play	VERB
ajlm-786	12	8	a	a	DET
ajlm-786	12	9	role	role	NOUN
ajlm-786	12	10	in	in	ADP
ajlm-786	12	11	the	the	DET
ajlm-786	12	12	aetiology	aetiology	NOUN
ajlm-786	12	13	and	and	CCONJ
ajlm-786	12	14	pathogenesis	pathogenesis	NOUN
ajlm-786	12	15	of	of	ADP
ajlm-786	12	16	a	a	DET
ajlm-786	12	17	number	number	NOUN
ajlm-786	12	18	of	of	ADP
ajlm-786	12	19	diseases	disease	NOUN
ajlm-786	12	20	including	include	VERB
ajlm-786	12	21	diabetes	diabetes	NOUN
ajlm-786	12	22	mellitus	mellitus	NOUN
ajlm-786	12	23	(	(	PUNCT
ajlm-786	12	24	dm).1,2	dm).1,2	ADJ
ajlm-786	12	25	serum	serum	NOUN
ajlm-786	12	26	uric	uric	ADJ
ajlm-786	12	27	acid	acid	PROPN
ajlm-786	12	28	(	(	PUNCT
ajlm-786	12	29	sua	sua	NOUN
ajlm-786	12	30	)	)	PUNCT
ajlm-786	12	31	has	have	AUX
ajlm-786	12	32	a	a	DET
ajlm-786	12	33	putative	putative	ADJ
ajlm-786	12	34	role	role	NOUN
ajlm-786	12	35	in	in	ADP
ajlm-786	12	36	the	the	DET
ajlm-786	12	37	development	development	NOUN
ajlm-786	12	38	of	of	ADP
ajlm-786	12	39	cardiovascular	cardiovascular	ADJ
ajlm-786	12	40	disease.3,4	disease.3,4	ADJ
ajlm-786	12	41	in	in	ADP
ajlm-786	12	42	a	a	DET
ajlm-786	12	43	recent	recent	ADJ
ajlm-786	12	44	study	study	NOUN
ajlm-786	12	45	conducted	conduct	VERB
ajlm-786	12	46	in	in	ADP
ajlm-786	12	47	south	south	PROPN
ajlm-786	12	48	africa	africa	PROPN
ajlm-786	12	49	,	,	PUNCT
ajlm-786	12	50	hyperuricaemia	hyperuricaemia	PROPN
ajlm-786	12	51	was	be	AUX
ajlm-786	12	52	associated	associate	VERB
ajlm-786	12	53	with	with	ADP
ajlm-786	12	54	an	an	DET
ajlm-786	12	55	increased	increase	VERB
ajlm-786	12	56	risk	risk	NOUN
ajlm-786	12	57	of	of	ADP
ajlm-786	12	58	mortality	mortality	NOUN
ajlm-786	12	59	among	among	ADP
ajlm-786	12	60	acute	acute	ADJ
ajlm-786	12	61	myocardial	myocardial	ADJ
ajlm-786	12	62	infarction	infarction	NOUN
ajlm-786	12	63	patients.5	patients.5	PROPN
ajlm-786	12	64	however	however	ADV
ajlm-786	12	65	,	,	PUNCT
ajlm-786	12	66	it	it	PRON
ajlm-786	12	67	remains	remain	VERB
ajlm-786	12	68	unclear	unclear	ADJ
ajlm-786	12	69	whether	whether	SCONJ
ajlm-786	12	70	increased	increase	VERB
ajlm-786	12	71	sua	sua	NOUN
ajlm-786	12	72	concentration	concentration	NOUN
ajlm-786	12	73	contributes	contribute	VERB
ajlm-786	12	74	to	to	ADP
ajlm-786	12	75	the	the	DET
ajlm-786	12	76	aetiology	aetiology	NOUN
ajlm-786	12	77	or	or	CCONJ
ajlm-786	12	78	if	if	SCONJ
ajlm-786	12	79	it	it	PRON
ajlm-786	12	80	is	be	AUX
ajlm-786	12	81	a	a	DET
ajlm-786	12	82	consequence	consequence	NOUN
ajlm-786	12	83	of	of	ADP
ajlm-786	12	84	these	these	DET
ajlm-786	12	85	conditions	condition	NOUN
ajlm-786	12	86	.	.	PUNCT
ajlm-786	13	1	the	the	DET
ajlm-786	13	2	role	role	NOUN
ajlm-786	13	3	of	of	ADP
ajlm-786	13	4	sua	sua	NOUN
ajlm-786	13	5	in	in	ADP
ajlm-786	13	6	type	type	NOUN
ajlm-786	13	7	2	2	NUM
ajlm-786	13	8	diabetes	diabetes	NOUN
ajlm-786	13	9	mellitus	mellitus	NOUN
ajlm-786	13	10	(	(	PUNCT
ajlm-786	13	11	t2	t2	NOUN
ajlm-786	13	12	dm	dm	NOUN
ajlm-786	13	13	)	)	PUNCT
ajlm-786	13	14	is	be	AUX
ajlm-786	13	15	inconclusive	inconclusive	ADJ
ajlm-786	13	16	.	.	PUNCT
ajlm-786	14	1	however	however	ADV
ajlm-786	14	2	,	,	PUNCT
ajlm-786	14	3	hyperuricaemia	hyperuricaemia	PROPN
ajlm-786	14	4	is	be	AUX
ajlm-786	14	5	associated	associate	VERB
ajlm-786	14	6	with	with	ADP
ajlm-786	14	7	obesity	obesity	NOUN
ajlm-786	14	8	and	and	CCONJ
ajlm-786	14	9	insulin	insulin	NOUN
ajlm-786	14	10	resistance,6	resistance,6	NOUN
ajlm-786	14	11	and	and	CCONJ
ajlm-786	14	12	cross	cross	ADJ
ajlm-786	14	13	-	-	ADJ
ajlm-786	14	14	sectional	sectional	ADJ
ajlm-786	14	15	data	datum	NOUN
ajlm-786	14	16	have	have	AUX
ajlm-786	14	17	shown	show	VERB
ajlm-786	14	18	that	that	SCONJ
ajlm-786	14	19	hyperuricaemia	hyperuricaemia	NOUN
ajlm-786	14	20	is	be	AUX
ajlm-786	14	21	prevalent	prevalent	ADJ
ajlm-786	14	22	among	among	ADP
ajlm-786	14	23	t2	t2	NOUN
ajlm-786	14	24	dm	dm	NUM
ajlm-786	14	25	patients.7	patients.7	VERB
ajlm-786	14	26	other	other	ADJ
ajlm-786	14	27	studies	study	NOUN
ajlm-786	14	28	have	have	AUX
ajlm-786	14	29	also	also	ADV
ajlm-786	14	30	reported	report	VERB
ajlm-786	14	31	that	that	SCONJ
ajlm-786	14	32	hyperuricaemia	hyperuricaemia	NOUN
ajlm-786	14	33	increases	increase	VERB
ajlm-786	14	34	the	the	DET
ajlm-786	14	35	risk	risk	NOUN
ajlm-786	14	36	of	of	ADP
ajlm-786	14	37	t2dm.8,9,10	t2dm.8,9,10	NOUN
ajlm-786	14	38	in	in	ADP
ajlm-786	14	39	a	a	DET
ajlm-786	14	40	meta	meta	ADJ
ajlm-786	14	41	-	-	PUNCT
ajlm-786	14	42	analysis	analysis	NOUN
ajlm-786	14	43	of	of	ADP
ajlm-786	14	44	11	11	NUM
ajlm-786	14	45	cohort	cohort	NOUN
ajlm-786	14	46	studies	study	NOUN
ajlm-786	14	47	,	,	PUNCT
ajlm-786	14	48	participants	participant	NOUN
ajlm-786	14	49	with	with	ADP
ajlm-786	14	50	hyperuricaemia	hyperuricaemia	PROPN
ajlm-786	14	51	had	have	VERB
ajlm-786	14	52	a	a	DET
ajlm-786	14	53	17	17	NUM
ajlm-786	14	54	%	%	NOUN
ajlm-786	14	55	increased	increase	VERB
ajlm-786	14	56	risk	risk	NOUN
ajlm-786	14	57	of	of	ADP
ajlm-786	14	58	developing	develop	VERB
ajlm-786	14	59	diabetes	diabetes	NOUN
ajlm-786	14	60	per	per	ADP
ajlm-786	14	61	1	1	NUM
ajlm-786	14	62	mg	mg	PROPN
ajlm-786	14	63	/	/	SYM
ajlm-786	14	64	dl	dl	NOUN
ajlm-786	14	65	increase	increase	NOUN
ajlm-786	14	66	in	in	ADP
ajlm-786	14	67	sua	sua	PROPN
ajlm-786	14	68	concentration.9	concentration.9	PROPN
ajlm-786	14	69	in	in	ADP
ajlm-786	14	70	another	another	DET
ajlm-786	14	71	meta	meta	ADJ
ajlm-786	14	72	-	-	PUNCT
ajlm-786	14	73	analysis	analysis	NOUN
ajlm-786	14	74	of	of	ADP
ajlm-786	14	75	eight	eight	NUM
ajlm-786	14	76	prospective	prospective	ADJ
ajlm-786	14	77	cohort	cohort	NOUN
ajlm-786	14	78	studies	study	NOUN
ajlm-786	14	79	,	,	PUNCT
ajlm-786	14	80	a	a	DET
ajlm-786	14	81	1	1	NUM
ajlm-786	14	82	mg	mg	PROPN
ajlm-786	14	83	/	/	SYM
ajlm-786	14	84	dl	dl	NOUN
ajlm-786	14	85	increase	increase	NOUN
ajlm-786	14	86	in	in	ADP
ajlm-786	14	87	sua	sua	PROPN
ajlm-786	14	88	resulted	result	VERB
ajlm-786	14	89	in	in	ADP
ajlm-786	14	90	a	a	DET
ajlm-786	14	91	6	6	NUM
ajlm-786	14	92	%	%	NOUN
ajlm-786	14	93	increase	increase	NOUN
ajlm-786	14	94	in	in	ADP
ajlm-786	14	95	the	the	DET
ajlm-786	14	96	risk	risk	NOUN
ajlm-786	14	97	of	of	ADP
ajlm-786	14	98	incident	incident	NOUN
ajlm-786	14	99	t2dm.8	t2dm.8	DET
ajlm-786	14	100	other	other	ADJ
ajlm-786	14	101	studies	study	NOUN
ajlm-786	14	102	have	have	AUX
ajlm-786	14	103	reported	report	VERB
ajlm-786	14	104	that	that	SCONJ
ajlm-786	14	105	hyperuricaemia	hyperuricaemia	NOUN
ajlm-786	14	106	predisposes	predispose	VERB
ajlm-786	14	107	individuals	individual	NOUN
ajlm-786	14	108	to	to	ADP
ajlm-786	14	109	the	the	DET
ajlm-786	14	110	development	development	NOUN
ajlm-786	14	111	of	of	ADP
ajlm-786	14	112	dm	dm	NUM
ajlm-786	14	113	complications.11	complications.11	NOUN
ajlm-786	14	114	among	among	ADP
ajlm-786	14	115	dm	dm	PROPN
ajlm-786	14	116	patients	patient	NOUN
ajlm-786	14	117	,	,	PUNCT
ajlm-786	14	118	poor	poor	ADJ
ajlm-786	14	119	glycaemic	glycaemic	NOUN
ajlm-786	14	120	control	control	NOUN
ajlm-786	14	121	increases	increase	VERB
ajlm-786	14	122	the	the	DET
ajlm-786	14	123	risk	risk	NOUN
ajlm-786	14	124	of	of	ADP
ajlm-786	14	125	microvascular	microvascular	ADJ
ajlm-786	14	126	complications.12	complications.12	NOUN
ajlm-786	14	127	the	the	DET
ajlm-786	14	128	measurement	measurement	NOUN
ajlm-786	14	129	of	of	ADP
ajlm-786	14	130	glycated	glycate	VERB
ajlm-786	14	131	haemoglobin	haemoglobin	NOUN
ajlm-786	14	132	(	(	PUNCT
ajlm-786	14	133	hba1c	hba1c	PROPN
ajlm-786	14	134	)	)	PUNCT
ajlm-786	14	135	and	and	CCONJ
ajlm-786	14	136	lipids	lipid	NOUN
ajlm-786	14	137	are	be	AUX
ajlm-786	14	138	used	use	VERB
ajlm-786	14	139	to	to	PART
ajlm-786	14	140	monitor	monitor	VERB
ajlm-786	14	141	dm	dm	NOUN
ajlm-786	14	142	patients	patient	NOUN
ajlm-786	14	143	,	,	PUNCT
ajlm-786	14	144	and	and	CCONJ
ajlm-786	14	145	adverse	adverse	ADJ
ajlm-786	14	146	changes	change	NOUN
ajlm-786	14	147	are	be	AUX
ajlm-786	14	148	associated	associate	VERB
ajlm-786	14	149	with	with	ADP
ajlm-786	14	150	the	the	DET
ajlm-786	14	151	risk	risk	NOUN
ajlm-786	14	152	of	of	ADP
ajlm-786	14	153	dm	dm	PROPN
ajlm-786	14	154	complications	complication	NOUN
ajlm-786	14	155	.	.	PUNCT
ajlm-786	15	1	hba1c	hba1c	PROPN
ajlm-786	15	2	is	be	AUX
ajlm-786	15	3	a	a	DET
ajlm-786	15	4	biochemical	biochemical	ADJ
ajlm-786	15	5	indicator	indicator	NOUN
ajlm-786	15	6	of	of	ADP
ajlm-786	15	7	chronic	chronic	ADJ
ajlm-786	15	8	glycaemia	glycaemia	NOUN
ajlm-786	15	9	,	,	PUNCT
ajlm-786	15	10	and	and	CCONJ
ajlm-786	15	11	high	high	ADJ
ajlm-786	15	12	values	value	NOUN
ajlm-786	15	13	indicate	indicate	VERB
ajlm-786	15	14	poor	poor	ADJ
ajlm-786	15	15	control.13	control.13	NOUN
ajlm-786	15	16	the	the	DET
ajlm-786	15	17	determination	determination	NOUN
ajlm-786	15	18	of	of	ADP
ajlm-786	15	19	total	total	ADJ
ajlm-786	15	20	cholesterol	cholesterol	NOUN
ajlm-786	15	21	,	,	PUNCT
ajlm-786	15	22	low	low	ADJ
ajlm-786	15	23	-	-	PUNCT
ajlm-786	15	24	density	density	NOUN
ajlm-786	15	25	lipoprotein	lipoprotein	ADJ
ajlm-786	15	26	(	(	PUNCT
ajlm-786	15	27	ldl	ldl	NOUN
ajlm-786	15	28	)	)	PUNCT
ajlm-786	15	29	and	and	CCONJ
ajlm-786	15	30	high	high	ADJ
ajlm-786	15	31	-	-	PUNCT
ajlm-786	15	32	density	density	NOUN
ajlm-786	15	33	lipoprotein	lipoprotein	ADJ
ajlm-786	15	34	(	(	PUNCT
ajlm-786	15	35	hdl	hdl	NOUN
ajlm-786	15	36	)	)	PUNCT
ajlm-786	15	37	cholesterol	cholesterol	NOUN
ajlm-786	15	38	,	,	PUNCT
ajlm-786	15	39	and	and	CCONJ
ajlm-786	15	40	triglycerides	triglyceride	NOUN
ajlm-786	15	41	provide	provide	VERB
ajlm-786	15	42	valuable	valuable	ADJ
ajlm-786	15	43	information	information	NOUN
ajlm-786	15	44	for	for	ADP
ajlm-786	15	45	the	the	DET
ajlm-786	15	46	prediction	prediction	NOUN
ajlm-786	15	47	of	of	ADP
ajlm-786	15	48	coronary	coronary	ADJ
ajlm-786	15	49	heart	heart	NOUN
ajlm-786	15	50	disease	disease	NOUN
ajlm-786	15	51	.	.	PUNCT
ajlm-786	16	1	triglyceride	triglyceride	ADJ
ajlm-786	16	2	concentration	concentration	NOUN
ajlm-786	16	3	has	have	VERB
ajlm-786	16	4	an	an	DET
ajlm-786	16	5	inverse	inverse	NOUN
ajlm-786	16	6	relationship	relationship	NOUN
ajlm-786	16	7	with	with	ADP
ajlm-786	16	8	hdl	hdl	PROPN
ajlm-786	16	9	cholesterol	cholesterol	PROPN
ajlm-786	16	10	concentration	concentration	NOUN
ajlm-786	16	11	in	in	ADP
ajlm-786	16	12	dm	dm	NOUN
ajlm-786	16	13	patients.13	patients.13	NOUN
ajlm-786	16	14	both	both	PRON
ajlm-786	16	15	hypertriglyceridemia	hypertriglyceridemia	NOUN
ajlm-786	16	16	and	and	CCONJ
ajlm-786	16	17	low	low	ADJ
ajlm-786	16	18	serum	serum	NOUN
ajlm-786	16	19	hdl	hdl	PROPN
ajlm-786	16	20	cholesterol	cholesterol	PROPN
ajlm-786	16	21	concentration	concentration	NOUN
ajlm-786	16	22	independently	independently	ADV
ajlm-786	16	23	increase	increase	VERB
ajlm-786	16	24	the	the	DET
ajlm-786	16	25	risk	risk	NOUN
ajlm-786	16	26	of	of	ADP
ajlm-786	16	27	developing	develop	VERB
ajlm-786	16	28	coronary	coronary	ADJ
ajlm-786	16	29	heart	heart	NOUN
ajlm-786	16	30	disease.13	disease.13	PROPN
ajlm-786	16	31	findings	finding	VERB
ajlm-786	16	32	on	on	ADP
ajlm-786	16	33	the	the	DET
ajlm-786	16	34	role	role	NOUN
ajlm-786	16	35	of	of	ADP
ajlm-786	16	36	sua	sua	NOUN
ajlm-786	16	37	in	in	ADP
ajlm-786	16	38	the	the	DET
ajlm-786	16	39	pathogenesis	pathogenesis	NOUN
ajlm-786	16	40	of	of	ADP
ajlm-786	16	41	dm	dm	PROPN
ajlm-786	16	42	are	be	AUX
ajlm-786	16	43	inconsistent	inconsistent	ADJ
ajlm-786	16	44	,	,	PUNCT
ajlm-786	16	45	and	and	CCONJ
ajlm-786	16	46	studies	study	NOUN
ajlm-786	16	47	on	on	ADP
ajlm-786	16	48	associations	association	NOUN
ajlm-786	16	49	between	between	ADP
ajlm-786	16	50	hyperuricaemia	hyperuricaemia	NOUN
ajlm-786	16	51	and	and	CCONJ
ajlm-786	16	52	the	the	DET
ajlm-786	16	53	development	development	NOUN
ajlm-786	16	54	of	of	ADP
ajlm-786	16	55	microvascular	microvascular	ADJ
ajlm-786	16	56	diseases	disease	NOUN
ajlm-786	16	57	among	among	ADP
ajlm-786	16	58	dm	dm	PROPN
ajlm-786	16	59	patients	patient	NOUN
ajlm-786	16	60	in	in	ADP
ajlm-786	16	61	african	african	ADJ
ajlm-786	16	62	populations	population	NOUN
ajlm-786	16	63	are	be	AUX
ajlm-786	16	64	lacking	lack	VERB
ajlm-786	16	65	.	.	PUNCT
ajlm-786	17	1	in	in	ADP
ajlm-786	17	2	this	this	DET
ajlm-786	17	3	study	study	NOUN
ajlm-786	17	4	we	we	PRON
ajlm-786	17	5	determined	determine	VERB
ajlm-786	17	6	the	the	DET
ajlm-786	17	7	prevalence	prevalence	NOUN
ajlm-786	17	8	of	of	ADP
ajlm-786	17	9	hyperuricaemia	hyperuricaemia	NOUN
ajlm-786	17	10	and	and	CCONJ
ajlm-786	17	11	its	its	PRON
ajlm-786	17	12	association	association	NOUN
ajlm-786	17	13	with	with	ADP
ajlm-786	17	14	hba1c	hba1c	PROPN
ajlm-786	17	15	and	and	CCONJ
ajlm-786	17	16	lipids	lipid	NOUN
ajlm-786	17	17	in	in	ADP
ajlm-786	17	18	t2	t2	NOUN
ajlm-786	17	19	dm	dm	PROPN
ajlm-786	17	20	patients	patient	NOUN
ajlm-786	17	21	in	in	ADP
ajlm-786	17	22	botswana	botswana	PROPN
ajlm-786	17	23	.	.	PUNCT
ajlm-786	18	1	methods	method	NOUN
ajlm-786	18	2	ethical	ethical	ADJ
ajlm-786	18	3	considerations	consideration	NOUN
ajlm-786	18	4	the	the	DET
ajlm-786	18	5	study	study	NOUN
ajlm-786	18	6	was	be	AUX
ajlm-786	18	7	approved	approve	VERB
ajlm-786	18	8	by	by	ADP
ajlm-786	18	9	the	the	DET
ajlm-786	18	10	university	university	PROPN
ajlm-786	18	11	of	of	ADP
ajlm-786	18	12	botswana	botswana	PROPN
ajlm-786	18	13	’s	’s	PART
ajlm-786	18	14	institutional	institutional	PROPN
ajlm-786	18	15	review	review	PROPN
ajlm-786	18	16	board	board	NOUN
ajlm-786	18	17	,	,	PUNCT
ajlm-786	18	18	the	the	DET
ajlm-786	18	19	ministry	ministry	PROPN
ajlm-786	18	20	of	of	ADP
ajlm-786	18	21	health	health	PROPN
ajlm-786	18	22	and	and	CCONJ
ajlm-786	18	23	wellness	wellness	NOUN
ajlm-786	18	24	health	health	NOUN
ajlm-786	18	25	research	research	NOUN
ajlm-786	18	26	unit	unit	NOUN
ajlm-786	18	27	(	(	PUNCT
ajlm-786	18	28	permit	permit	NOUN
ajlm-786	18	29	number	number	NOUN
ajlm-786	18	30	hpdme	hpdme	NOUN
ajlm-786	18	31	:	:	PUNCT
ajlm-786	18	32	13/18/1	13/18/1	NUM
ajlm-786	18	33	vol	vol	NOUN
ajlm-786	18	34	x	x	PUNCT
ajlm-786	19	1	[	[	X
ajlm-786	19	2	619	619	NUM
ajlm-786	19	3	]	]	PUNCT
ajlm-786	19	4	)	)	PUNCT
ajlm-786	19	5	and	and	CCONJ
ajlm-786	19	6	the	the	DET
ajlm-786	19	7	research	research	NOUN
ajlm-786	19	8	and	and	CCONJ
ajlm-786	19	9	ethics	ethic	NOUN
ajlm-786	19	10	committee	committee	PROPN
ajlm-786	19	11	of	of	ADP
ajlm-786	19	12	princess	princess	PROPN
ajlm-786	19	13	marina	marina	PROPN
ajlm-786	19	14	hospital	hospital	PROPN
ajlm-786	19	15	(	(	PUNCT
ajlm-786	19	16	permit	permit	NOUN
ajlm-786	19	17	number	number	NOUN
ajlm-786	19	18	pmh	pmh	NOUN
ajlm-786	19	19	5/79	5/79	NUM
ajlm-786	19	20	[	[	X
ajlm-786	19	21	268	268	NUM
ajlm-786	19	22	-	-	SYM
ajlm-786	19	23	2	2	NUM
ajlm-786	19	24	-	-	NUM
ajlm-786	19	25	2016	2016	NUM
ajlm-786	19	26	]	]	PUNCT
ajlm-786	19	27	)	)	PUNCT
ajlm-786	19	28	.	.	PUNCT
ajlm-786	20	1	no	no	DET
ajlm-786	20	2	individual	individual	ADJ
ajlm-786	20	3	consent	consent	NOUN
ajlm-786	20	4	was	be	AUX
ajlm-786	20	5	obtained	obtain	VERB
ajlm-786	20	6	from	from	ADP
ajlm-786	20	7	the	the	DET
ajlm-786	20	8	patients	patient	NOUN
ajlm-786	20	9	.	.	PUNCT
ajlm-786	21	1	study	study	NOUN
ajlm-786	21	2	population	population	NOUN
ajlm-786	21	3	we	we	PRON
ajlm-786	21	4	conducted	conduct	VERB
ajlm-786	21	5	a	a	DET
ajlm-786	21	6	cross	cross	ADJ
ajlm-786	21	7	-	-	ADJ
ajlm-786	21	8	sectional	sectional	ADJ
ajlm-786	21	9	study	study	NOUN
ajlm-786	21	10	of	of	ADP
ajlm-786	21	11	residual	residual	ADJ
ajlm-786	21	12	samples	sample	NOUN
ajlm-786	21	13	from	from	ADP
ajlm-786	21	14	334	334	NUM
ajlm-786	21	15	t2	t2	NOUN
ajlm-786	21	16	dm	dm	PROPN
ajlm-786	21	17	patients	patient	NOUN
ajlm-786	21	18	attending	attend	VERB
ajlm-786	21	19	a	a	DET
ajlm-786	21	20	dm	dm	PROPN
ajlm-786	21	21	clinic	clinic	NOUN
ajlm-786	21	22	in	in	ADP
ajlm-786	21	23	gaborone	gaborone	PROPN
ajlm-786	21	24	city	city	NOUN
ajlm-786	21	25	,	,	PUNCT
ajlm-786	21	26	during	during	ADP
ajlm-786	21	27	the	the	DET
ajlm-786	21	28	period	period	NOUN
ajlm-786	21	29	september	september	PROPN
ajlm-786	21	30	–	–	PUNCT
ajlm-786	21	31	december	december	PROPN
ajlm-786	21	32	2016	2016	NUM
ajlm-786	21	33	.	.	PUNCT
ajlm-786	22	1	the	the	DET
ajlm-786	22	2	criteria	criterion	NOUN
ajlm-786	22	3	for	for	ADP
ajlm-786	22	4	inclusion	inclusion	NOUN
ajlm-786	22	5	were	be	AUX
ajlm-786	22	6	age	age	NOUN
ajlm-786	22	7	≥	≥	NUM
ajlm-786	22	8	18	18	NUM
ajlm-786	22	9	years	year	NOUN
ajlm-786	22	10	and	and	CCONJ
ajlm-786	22	11	a	a	DET
ajlm-786	22	12	known	know	VERB
ajlm-786	22	13	history	history	NOUN
ajlm-786	22	14	of	of	ADP
ajlm-786	22	15	t2	t2	PROPN
ajlm-786	22	16	dm	dm	PROPN
ajlm-786	22	17	.	.	PROPN
ajlm-786	22	18	minors	minor	NOUN
ajlm-786	22	19	(	(	PUNCT
ajlm-786	22	20	<	<	X
ajlm-786	22	21	18	18	NUM
ajlm-786	22	22	years	year	NOUN
ajlm-786	22	23	)	)	PUNCT
ajlm-786	22	24	with	with	SCONJ
ajlm-786	22	25	t2	t2	NOUN
ajlm-786	22	26	dm	dm	NUM
ajlm-786	22	27	were	be	AUX
ajlm-786	22	28	excluded	exclude	VERB
ajlm-786	22	29	from	from	ADP
ajlm-786	22	30	the	the	DET
ajlm-786	22	31	study	study	NOUN
ajlm-786	22	32	.	.	PUNCT
ajlm-786	23	1	the	the	DET
ajlm-786	23	2	samples	sample	NOUN
ajlm-786	23	3	enrolled	enrol	VERB
ajlm-786	23	4	in	in	ADP
ajlm-786	23	5	the	the	DET
ajlm-786	23	6	study	study	NOUN
ajlm-786	23	7	were	be	AUX
ajlm-786	23	8	collected	collect	VERB
ajlm-786	23	9	as	as	ADP
ajlm-786	23	10	part	part	NOUN
ajlm-786	23	11	of	of	ADP
ajlm-786	23	12	clinical	clinical	ADJ
ajlm-786	23	13	care	care	NOUN
ajlm-786	23	14	and	and	CCONJ
ajlm-786	23	15	were	be	AUX
ajlm-786	23	16	de	de	ADJ
ajlm-786	23	17	-	-	VERB
ajlm-786	23	18	identified	identify	VERB
ajlm-786	23	19	prior	prior	ADV
ajlm-786	23	20	to	to	ADP
ajlm-786	23	21	inclusion	inclusion	NOUN
ajlm-786	23	22	in	in	ADP
ajlm-786	23	23	the	the	DET
ajlm-786	23	24	study	study	NOUN
ajlm-786	23	25	,	,	PUNCT
ajlm-786	23	26	as	as	SCONJ
ajlm-786	23	27	recommended	recommend	VERB
ajlm-786	23	28	in	in	ADP
ajlm-786	23	29	the	the	DET
ajlm-786	23	30	international	international	ADJ
ajlm-786	23	31	organization	organization	NOUN
ajlm-786	23	32	for	for	ADP
ajlm-786	23	33	standardization	standardization	NOUN
ajlm-786	23	34	’s	’s	PART
ajlm-786	23	35	15189	15189	NUM
ajlm-786	23	36	standard	standard	NOUN
ajlm-786	23	37	.	.	PUNCT
ajlm-786	24	1	the	the	DET
ajlm-786	24	2	clients	client	NOUN
ajlm-786	24	3	’	’	PART
ajlm-786	24	4	identities	identity	NOUN
ajlm-786	24	5	were	be	AUX
ajlm-786	24	6	not	not	PART
ajlm-786	24	7	revealed	reveal	VERB
ajlm-786	24	8	to	to	PART
ajlm-786	24	9	study	study	VERB
ajlm-786	24	10	staff	staff	NOUN
ajlm-786	24	11	and	and	CCONJ
ajlm-786	24	12	confidential	confidential	ADJ
ajlm-786	24	13	information	information	NOUN
ajlm-786	24	14	was	be	AUX
ajlm-786	24	15	only	only	ADV
ajlm-786	24	16	made	make	VERB
ajlm-786	24	17	accessible	accessible	ADJ
ajlm-786	24	18	to	to	ADP
ajlm-786	24	19	authorised	authorise	VERB
ajlm-786	24	20	persons	person	NOUN
ajlm-786	24	21	.	.	PUNCT
ajlm-786	25	1	laboratory	laboratory	NOUN
ajlm-786	25	2	investigations	investigation	NOUN
ajlm-786	25	3	laboratory	laboratory	NOUN
ajlm-786	25	4	tests	test	NOUN
ajlm-786	25	5	were	be	AUX
ajlm-786	25	6	performed	perform	VERB
ajlm-786	25	7	on	on	ADP
ajlm-786	25	8	au480	au480	NOUN
ajlm-786	25	9	chemistry	chemistry	NOUN
ajlm-786	25	10	analyzer	analyzer	NOUN
ajlm-786	25	11	(	(	PUNCT
ajlm-786	25	12	beckman	beckman	PROPN
ajlm-786	25	13	coulter	coulter	PROPN
ajlm-786	25	14	inc	inc	PROPN
ajlm-786	25	15	,	,	PUNCT
ajlm-786	25	16	brea	brea	PROPN
ajlm-786	25	17	,	,	PUNCT
ajlm-786	25	18	california	california	PROPN
ajlm-786	25	19	,	,	PUNCT
ajlm-786	25	20	united	united	PROPN
ajlm-786	25	21	states	states	PROPN
ajlm-786	25	22	)	)	PUNCT
ajlm-786	25	23	.	.	PUNCT
ajlm-786	26	1	in	in	ADP
ajlm-786	26	2	some	some	DET
ajlm-786	26	3	cases	case	NOUN
ajlm-786	26	4	,	,	PUNCT
ajlm-786	26	5	the	the	DET
ajlm-786	26	6	sample	sample	NOUN
ajlm-786	26	7	volume	volume	NOUN
ajlm-786	26	8	was	be	AUX
ajlm-786	26	9	insufficient	insufficient	ADJ
ajlm-786	26	10	to	to	PART
ajlm-786	26	11	perform	perform	VERB
ajlm-786	26	12	all	all	DET
ajlm-786	26	13	the	the	DET
ajlm-786	26	14	tests	test	NOUN
ajlm-786	26	15	or	or	CCONJ
ajlm-786	26	16	the	the	DET
ajlm-786	26	17	data	datum	NOUN
ajlm-786	26	18	were	be	AUX
ajlm-786	26	19	missing	miss	VERB
ajlm-786	26	20	from	from	ADP
ajlm-786	26	21	the	the	DET
ajlm-786	26	22	patient	patient	NOUN
ajlm-786	26	23	’s	’s	PART
ajlm-786	26	24	records	record	NOUN
ajlm-786	26	25	.	.	PUNCT
ajlm-786	27	1	the	the	DET
ajlm-786	27	2	analyser	analyser	NOUN
ajlm-786	27	3	was	be	AUX
ajlm-786	27	4	calibrated	calibrate	VERB
ajlm-786	27	5	and	and	CCONJ
ajlm-786	27	6	samples	sample	NOUN
ajlm-786	27	7	processed	process	VERB
ajlm-786	27	8	according	accord	VERB
ajlm-786	27	9	to	to	ADP
ajlm-786	27	10	the	the	DET
ajlm-786	27	11	manufacturer	manufacturer	NOUN
ajlm-786	27	12	’s	’s	PART
ajlm-786	27	13	instructions	instruction	NOUN
ajlm-786	27	14	using	use	VERB
ajlm-786	27	15	reagents	reagent	NOUN
ajlm-786	27	16	provided	provide	VERB
ajlm-786	27	17	by	by	ADP
ajlm-786	27	18	the	the	DET
ajlm-786	27	19	manufacturer	manufacturer	NOUN
ajlm-786	27	20	.	.	PUNCT
ajlm-786	28	1	serum	serum	PROPN
ajlm-786	28	2	uric	uric	PROPN
ajlm-786	28	3	acid	acid	PROPN
ajlm-786	28	4	was	be	AUX
ajlm-786	28	5	measured	measure	VERB
ajlm-786	28	6	using	use	VERB
ajlm-786	28	7	the	the	DET
ajlm-786	28	8	uricase	uricase	ADJ
ajlm-786	28	9	/	/	SYM
ajlm-786	28	10	peroxidase	peroxidase	ADJ
ajlm-786	28	11	enzymatic	enzymatic	ADJ
ajlm-786	28	12	method	method	NOUN
ajlm-786	28	13	,	,	PUNCT
ajlm-786	28	14	and	and	CCONJ
ajlm-786	28	15	hyperuricaemia	hyperuricaemia	NOUN
ajlm-786	28	16	was	be	AUX
ajlm-786	28	17	defined	define	VERB
ajlm-786	28	18	as	as	ADP
ajlm-786	28	19	sua	sua	PROPN
ajlm-786	28	20	>	>	X
ajlm-786	28	21	400	400	NUM
ajlm-786	28	22	µmol	µmol	ADP
ajlm-786	28	23	/	/	SYM
ajlm-786	28	24	l.	l.	NOUN
ajlm-786	28	25	this	this	DET
ajlm-786	28	26	cut	cut	NOUN
ajlm-786	28	27	-	-	PUNCT
ajlm-786	28	28	off	off	NOUN
ajlm-786	28	29	is	be	AUX
ajlm-786	28	30	the	the	DET
ajlm-786	28	31	upper	upper	ADJ
ajlm-786	28	32	reference	reference	NOUN
ajlm-786	28	33	limit	limit	NOUN
ajlm-786	28	34	used	use	VERB
ajlm-786	28	35	to	to	PART
ajlm-786	28	36	define	define	VERB
ajlm-786	28	37	hyperuricaemia	hyperuricaemia	NOUN
ajlm-786	28	38	in	in	ADP
ajlm-786	28	39	botswana	botswana	PROPN
ajlm-786	28	40	.	.	PUNCT
ajlm-786	29	1	hba1c	hba1c	PROPN
ajlm-786	29	2	was	be	AUX
ajlm-786	29	3	measured	measure	VERB
ajlm-786	29	4	using	use	VERB
ajlm-786	29	5	a	a	DET
ajlm-786	29	6	latex	latex	NOUN
ajlm-786	29	7	agglutination	agglutination	NOUN
ajlm-786	29	8	assay	assay	PROPN
ajlm-786	29	9	.	.	PUNCT
ajlm-786	30	1	briefly	briefly	ADV
ajlm-786	30	2	,	,	PUNCT
ajlm-786	30	3	a	a	DET
ajlm-786	30	4	synthetic	synthetic	ADJ
ajlm-786	30	5	polymer	polymer	NOUN
ajlm-786	30	6	containing	contain	VERB
ajlm-786	30	7	multiple	multiple	ADJ
ajlm-786	30	8	copies	copy	NOUN
ajlm-786	30	9	of	of	ADP
ajlm-786	30	10	the	the	DET
ajlm-786	30	11	immunoreactive	immunoreactive	ADJ
ajlm-786	30	12	portion	portion	NOUN
ajlm-786	30	13	of	of	ADP
ajlm-786	30	14	hba1c	hba1c	PROPN
ajlm-786	30	15	agglutinates	agglutinate	VERB
ajlm-786	30	16	with	with	ADP
ajlm-786	30	17	latex	latex	NOUN
ajlm-786	30	18	coated	coat	VERB
ajlm-786	30	19	with	with	ADP
ajlm-786	30	20	hba1c	hba1c	ADJ
ajlm-786	30	21	-	-	ADJ
ajlm-786	30	22	specific	specific	ADJ
ajlm-786	30	23	mouse	mouse	NOUN
ajlm-786	30	24	monoclonal	monoclonal	NOUN
ajlm-786	30	25	antibodies	antibodie	VERB
ajlm-786	30	26	.	.	PUNCT
ajlm-786	31	1	total	total	ADJ
ajlm-786	31	2	cholesterol	cholesterol	PROPN
ajlm-786	31	3	,	,	PUNCT
ajlm-786	31	4	hdl	hdl	PROPN
ajlm-786	31	5	cholesterol	cholesterol	PROPN
ajlm-786	31	6	,	,	PUNCT
ajlm-786	31	7	ldl	ldl	NOUN
ajlm-786	31	8	cholesterol	cholesterol	NOUN
ajlm-786	31	9	and	and	CCONJ
ajlm-786	31	10	triglycerides	triglyceride	NOUN
ajlm-786	31	11	were	be	AUX
ajlm-786	31	12	determined	determine	VERB
ajlm-786	31	13	by	by	ADP
ajlm-786	31	14	routine	routine	ADJ
ajlm-786	31	15	enzymatic	enzymatic	ADJ
ajlm-786	31	16	methods	method	NOUN
ajlm-786	31	17	.	.	PUNCT
ajlm-786	32	1	creatinine	creatinine	NOUN
ajlm-786	32	2	was	be	AUX
ajlm-786	32	3	measured	measure	VERB
ajlm-786	32	4	using	use	VERB
ajlm-786	32	5	a	a	DET
ajlm-786	32	6	kinetic	kinetic	ADJ
ajlm-786	32	7	modification	modification	NOUN
ajlm-786	32	8	of	of	ADP
ajlm-786	32	9	the	the	DET
ajlm-786	32	10	jaffe	jaffe	PROPN
ajlm-786	32	11	procedure.14	procedure.14	PROPN
ajlm-786	32	12	statistical	statistical	ADJ
ajlm-786	32	13	analysis	analysis	NOUN
ajlm-786	32	14	the	the	DET
ajlm-786	32	15	results	result	NOUN
ajlm-786	32	16	were	be	AUX
ajlm-786	32	17	analysed	analyse	VERB
ajlm-786	32	18	using	use	VERB
ajlm-786	32	19	the	the	DET
ajlm-786	32	20	statistical	statistical	ADJ
ajlm-786	32	21	package	package	NOUN
ajlm-786	32	22	for	for	ADP
ajlm-786	32	23	social	social	ADJ
ajlm-786	32	24	sciences	science	NOUN
ajlm-786	32	25	version	version	NOUN
ajlm-786	32	26	24	24	NUM
ajlm-786	32	27	statistical	statistical	ADJ
ajlm-786	32	28	software	software	NOUN
ajlm-786	32	29	(	(	PUNCT
ajlm-786	32	30	ibm	ibm	PROPN
ajlm-786	32	31	corporation	corporation	NOUN
ajlm-786	32	32	,	,	PUNCT
ajlm-786	32	33	new	new	PROPN
ajlm-786	32	34	york	york	PROPN
ajlm-786	32	35	city	city	PROPN
ajlm-786	32	36	,	,	PUNCT
ajlm-786	32	37	new	new	PROPN
ajlm-786	32	38	york	york	PROPN
ajlm-786	32	39	,	,	PUNCT
ajlm-786	32	40	united	united	PROPN
ajlm-786	32	41	states	states	PROPN
ajlm-786	32	42	)	)	PUNCT
ajlm-786	32	43	.	.	PUNCT
ajlm-786	33	1	all	all	DET
ajlm-786	33	2	quantitative	quantitative	ADJ
ajlm-786	33	3	variables	variable	NOUN
ajlm-786	33	4	were	be	AUX
ajlm-786	33	5	expressed	express	VERB
ajlm-786	33	6	as	as	ADP
ajlm-786	33	7	mean	mean	NOUN
ajlm-786	33	8	±	±	NUM
ajlm-786	33	9	standard	standard	ADJ
ajlm-786	33	10	deviation	deviation	NOUN
ajlm-786	33	11	or	or	CCONJ
ajlm-786	33	12	median	median	NOUN
ajlm-786	33	13	with	with	ADP
ajlm-786	33	14	interquartile	interquartile	ADJ
ajlm-786	33	15	range	range	NOUN
ajlm-786	33	16	(	(	PUNCT
ajlm-786	33	17	iqr	iqr	NOUN
ajlm-786	33	18	)	)	PUNCT
ajlm-786	33	19	.	.	PUNCT
ajlm-786	34	1	categorical	categorical	ADJ
ajlm-786	34	2	variables	variable	NOUN
ajlm-786	34	3	were	be	AUX
ajlm-786	34	4	expressed	express	VERB
ajlm-786	34	5	as	as	ADP
ajlm-786	34	6	proportions	proportion	NOUN
ajlm-786	34	7	with	with	ADP
ajlm-786	34	8	estimated	estimate	VERB
ajlm-786	34	9	95	95	NUM
ajlm-786	34	10	%	%	NOUN
ajlm-786	34	11	confidence	confidence	NOUN
ajlm-786	34	12	intervals	interval	NOUN
ajlm-786	34	13	(	(	PUNCT
ajlm-786	34	14	ci	ci	NOUN
ajlm-786	34	15	)	)	PUNCT
ajlm-786	34	16	.	.	PUNCT
ajlm-786	35	1	comparisons	comparison	NOUN
ajlm-786	35	2	of	of	ADP
ajlm-786	35	3	hba1c	hba1c	PROPN
ajlm-786	35	4	concentration	concentration	NOUN
ajlm-786	35	5	according	accord	VERB
ajlm-786	35	6	to	to	ADP
ajlm-786	35	7	sex	sex	NOUN
ajlm-786	35	8	or	or	CCONJ
ajlm-786	35	9	sua	sua	NOUN
ajlm-786	35	10	categories	category	NOUN
ajlm-786	35	11	were	be	AUX
ajlm-786	35	12	conducted	conduct	VERB
ajlm-786	35	13	using	use	VERB
ajlm-786	35	14	an	an	DET
ajlm-786	35	15	independent	independent	ADJ
ajlm-786	35	16	samples	sample	NOUN
ajlm-786	35	17	t	t	NOUN
ajlm-786	35	18	-	-	PUNCT
ajlm-786	35	19	test	test	NOUN
ajlm-786	35	20	,	,	PUNCT
ajlm-786	35	21	or	or	CCONJ
ajlm-786	35	22	the	the	DET
ajlm-786	35	23	mann	mann	PROPN
ajlm-786	35	24	-	-	PUNCT
ajlm-786	35	25	whitney	whitney	PROPN
ajlm-786	35	26	test	test	NOUN
ajlm-786	35	27	was	be	AUX
ajlm-786	35	28	used	use	VERB
ajlm-786	35	29	to	to	PART
ajlm-786	35	30	compare	compare	VERB
ajlm-786	35	31	medians	median	NOUN
ajlm-786	35	32	for	for	ADP
ajlm-786	35	33	non	non	ADJ
ajlm-786	35	34	-	-	ADJ
ajlm-786	35	35	parametric	parametric	ADJ
ajlm-786	35	36	data	datum	NOUN
ajlm-786	35	37	.	.	PUNCT
ajlm-786	36	1	results	result	NOUN
ajlm-786	36	2	were	be	AUX
ajlm-786	36	3	considered	consider	VERB
ajlm-786	36	4	statistically	statistically	ADV
ajlm-786	36	5	significant	significant	ADJ
ajlm-786	36	6	if	if	SCONJ
ajlm-786	36	7	p	p	X
ajlm-786	36	8	<	<	X
ajlm-786	36	9	0.05	0.05	NUM
ajlm-786	36	10	.	.	PUNCT
ajlm-786	36	11	box	box	NOUN
ajlm-786	36	12	-	-	PUNCT
ajlm-786	36	13	and	and	CCONJ
ajlm-786	36	14	-	-	PUNCT
ajlm-786	36	15	whisker	whisker	NOUN
ajlm-786	36	16	plots	plot	NOUN
ajlm-786	36	17	were	be	AUX
ajlm-786	36	18	used	use	VERB
ajlm-786	36	19	to	to	PART
ajlm-786	36	20	show	show	VERB
ajlm-786	36	21	differences	difference	NOUN
ajlm-786	36	22	in	in	ADP
ajlm-786	36	23	serum	serum	NOUN
ajlm-786	36	24	creatinine	creatinine	NOUN
ajlm-786	36	25	concentration	concentration	NOUN
ajlm-786	36	26	and	and	CCONJ
ajlm-786	36	27	hba1c	hba1c	NOUN
ajlm-786	36	28	according	accord	VERB
ajlm-786	36	29	to	to	ADP
ajlm-786	36	30	uric	uric	ADJ
ajlm-786	36	31	acid	acid	NOUN
ajlm-786	36	32	category	category	NOUN
ajlm-786	36	33	.	.	PUNCT
ajlm-786	37	1	results	result	VERB
ajlm-786	37	2	samples	sample	NOUN
ajlm-786	37	3	from	from	ADP
ajlm-786	37	4	334	334	NUM
ajlm-786	37	5	patients	patient	NOUN
ajlm-786	37	6	(	(	PUNCT
ajlm-786	37	7	236	236	NUM
ajlm-786	37	8	women	woman	NOUN
ajlm-786	37	9	)	)	PUNCT
ajlm-786	37	10	with	with	ADP
ajlm-786	37	11	t2	t2	NOUN
ajlm-786	37	12	dm	dm	X
ajlm-786	37	13	of	of	ADP
ajlm-786	37	14	unknown	unknown	ADJ
ajlm-786	37	15	duration	duration	NOUN
ajlm-786	37	16	were	be	AUX
ajlm-786	37	17	studied	study	VERB
ajlm-786	37	18	.	.	PUNCT
ajlm-786	38	1	ninety	ninety	NUM
ajlm-786	38	2	-	-	PUNCT
ajlm-786	38	3	two	two	NUM
ajlm-786	38	4	patients	patient	NOUN
ajlm-786	38	5	(	(	PUNCT
ajlm-786	38	6	28	28	NUM
ajlm-786	38	7	%	%	NOUN
ajlm-786	38	8	,	,	PUNCT
ajlm-786	38	9	95	95	NUM
ajlm-786	38	10	%	%	NOUN
ajlm-786	38	11	ci	ci	NOUN
ajlm-786	38	12	23.1–32.9	23.1–32.9	NUM
ajlm-786	38	13	)	)	PUNCT
ajlm-786	38	14	had	have	VERB
ajlm-786	38	15	hyperuricaemia	hyperuricaemia	NOUN
ajlm-786	38	16	and	and	CCONJ
ajlm-786	38	17	the	the	DET
ajlm-786	38	18	prevalence	prevalence	NOUN
ajlm-786	38	19	was	be	AUX
ajlm-786	38	20	comparable	comparable	ADJ
ajlm-786	38	21	between	between	ADP
ajlm-786	38	22	sexes	sex	NOUN
ajlm-786	38	23	(	(	PUNCT
ajlm-786	39	1	25	25	NUM
ajlm-786	39	2	%	%	NOUN
ajlm-786	39	3	[	[	X
ajlm-786	39	4	95	95	NUM
ajlm-786	39	5	%	%	NOUN
ajlm-786	39	6	ci	ci	NOUN
ajlm-786	39	7	19.4–30.6	19.4–30.6	NUM
ajlm-786	39	8	]	]	PUNCT
ajlm-786	39	9	in	in	ADP
ajlm-786	39	10	women	woman	NOUN
ajlm-786	39	11	compared	compare	VERB
ajlm-786	39	12	to	to	ADP
ajlm-786	39	13	33	33	NUM
ajlm-786	39	14	%	%	NOUN
ajlm-786	40	1	[	[	X
ajlm-786	40	2	95	95	NUM
ajlm-786	40	3	%	%	NOUN
ajlm-786	40	4	ci	ci	NOUN
ajlm-786	40	5	23.5–42.5	23.5–42.5	NUM
ajlm-786	40	6	]	]	X
ajlm-786	40	7	in	in	ADP
ajlm-786	40	8	men	man	NOUN
ajlm-786	40	9	,	,	PUNCT
ajlm-786	40	10	p	p	NOUN
ajlm-786	40	11	=	=	NOUN
ajlm-786	40	12	0.182	0.182	NUM
ajlm-786	40	13	)	)	PUNCT
ajlm-786	40	14	.	.	PUNCT
ajlm-786	41	1	hba1c	hba1c	NOUN
ajlm-786	41	2	levels	level	NOUN
ajlm-786	41	3	were	be	AUX
ajlm-786	41	4	comparable	comparable	ADJ
ajlm-786	41	5	between	between	ADP
ajlm-786	41	6	sua	sua	PROPN
ajlm-786	41	7	categories	category	NOUN
ajlm-786	41	8	;	;	PUNCT
ajlm-786	41	9	median	median	NOUN
ajlm-786	41	10	7.1	7.1	NUM
ajlm-786	41	11	%	%	NOUN
ajlm-786	41	12	(	(	PUNCT
ajlm-786	41	13	iqr	iqr	NOUN
ajlm-786	41	14	6.4–8.9	6.4–8.9	NOUN
ajlm-786	41	15	)	)	PUNCT
ajlm-786	41	16	in	in	ADP
ajlm-786	41	17	t2	t2	NOUN
ajlm-786	41	18	dm	dm	NUM
ajlm-786	41	19	patients	patient	NOUN
ajlm-786	41	20	with	with	ADP
ajlm-786	41	21	hyperuricaemia	hyperuricaemia	NOUN
ajlm-786	41	22	compared	compare	VERB
ajlm-786	41	23	to	to	ADP
ajlm-786	41	24	median	median	NOUN
ajlm-786	41	25	7.4	7.4	NUM
ajlm-786	41	26	%	%	NOUN
ajlm-786	41	27	(	(	PUNCT
ajlm-786	41	28	iqr	iqr	NOUN
ajlm-786	41	29	6.3–9.3	6.3–9.3	NOUN
ajlm-786	41	30	)	)	PUNCT
ajlm-786	41	31	in	in	ADP
ajlm-786	41	32	t2	t2	NOUN
ajlm-786	41	33	dm	dm	NUM
ajlm-786	41	34	patients	patient	NOUN
ajlm-786	41	35	with	with	ADP
ajlm-786	41	36	normal	normal	ADJ
ajlm-786	41	37	sua	sua	NOUN
ajlm-786	41	38	,	,	PUNCT
ajlm-786	41	39	p	p	NOUN
ajlm-786	41	40	=	=	PROPN
ajlm-786	41	41	0.379	0.379	NUM
ajlm-786	41	42	(	(	PUNCT
ajlm-786	41	43	table	table	NOUN
ajlm-786	41	44	1	1	NUM
ajlm-786	41	45	)	)	PUNCT
ajlm-786	41	46	.	.	PUNCT
ajlm-786	42	1	similarly	similarly	ADV
ajlm-786	42	2	,	,	PUNCT
ajlm-786	42	3	hyperuricaemia	hyperuricaemia	PROPN
ajlm-786	42	4	had	have	VERB
ajlm-786	42	5	no	no	DET
ajlm-786	42	6	effect	effect	NOUN
ajlm-786	42	7	on	on	ADP
ajlm-786	42	8	total	total	ADJ
ajlm-786	42	9	and	and	CCONJ
ajlm-786	42	10	ldl	ldl	VERB
ajlm-786	42	11	cholesterol	cholesterol	NOUN
ajlm-786	42	12	levels	level	NOUN
ajlm-786	42	13	,	,	PUNCT
ajlm-786	42	14	p	p	PRON
ajlm-786	42	15	≥	≥	NUM
ajlm-786	42	16	0.321	0.321	NUM
ajlm-786	42	17	.	.	PUNCT
ajlm-786	43	1	there	there	PRON
ajlm-786	43	2	was	be	VERB
ajlm-786	43	3	a	a	DET
ajlm-786	43	4	tendency	tendency	NOUN
ajlm-786	43	5	for	for	ADP
ajlm-786	43	6	lower	low	ADJ
ajlm-786	43	7	hdl	hdl	X
ajlm-786	43	8	cholesterol	cholesterol	NOUN
ajlm-786	43	9	among	among	ADP
ajlm-786	43	10	patients	patient	NOUN
ajlm-786	43	11	with	with	ADP
ajlm-786	43	12	hyperuricaemia	hyperuricaemia	NOUN
ajlm-786	43	13	,	,	PUNCT
ajlm-786	43	14	p	p	X
ajlm-786	43	15	=	=	NOUN
ajlm-786	43	16	0.090	0.090	NUM
ajlm-786	43	17	.	.	PUNCT
ajlm-786	44	1	median	median	ADJ
ajlm-786	44	2	triglyceride	triglyceride	ADJ
ajlm-786	44	3	levels	level	NOUN
ajlm-786	44	4	were	be	AUX
ajlm-786	44	5	higher	high	ADJ
ajlm-786	44	6	among	among	ADP
ajlm-786	44	7	patients	patient	NOUN
ajlm-786	44	8	with	with	ADP
ajlm-786	44	9	hyperuricaemia	hyperuricaemia	NOUN
ajlm-786	44	10	(	(	PUNCT
ajlm-786	44	11	1.99	1.99	NUM
ajlm-786	44	12	mmol	mmol	NOUN
ajlm-786	44	13	/	/	SYM
ajlm-786	44	14	l	l	NOUN
ajlm-786	45	1	[	[	X
ajlm-786	45	2	iqr	iqr	X
ajlm-786	45	3	1.48–2.57	1.48–2.57	X
ajlm-786	45	4	]	]	X
ajlm-786	45	5	vs	vs	ADP
ajlm-786	45	6	1.72	1.72	NUM
ajlm-786	45	7	mmol	mmol	NOUN
ajlm-786	45	8	/	/	SYM
ajlm-786	45	9	l	l	NOUN
ajlm-786	45	10	[	[	X
ajlm-786	45	11	iqr	iqr	X
ajlm-786	45	12	1.19–2.57	1.19–2.57	PROPN
ajlm-786	45	13	]	]	PUNCT
ajlm-786	45	14	,	,	PUNCT
ajlm-786	45	15	p	p	X
ajlm-786	45	16	=	=	NOUN
ajlm-786	45	17	0.032	0.032	NUM
ajlm-786	45	18	)	)	PUNCT
ajlm-786	45	19	;	;	PUNCT
ajlm-786	45	20	similarly	similarly	ADV
ajlm-786	45	21	,	,	PUNCT
ajlm-786	45	22	t2	t2	NOUN
ajlm-786	45	23	dm	dm	PROPN
ajlm-786	45	24	patients	patient	NOUN
ajlm-786	45	25	with	with	ADP
ajlm-786	45	26	hyperuricaemia	hyperuricaemia	NOUN
ajlm-786	45	27	had	have	AUX
ajlm-786	45	28	higher	high	ADJ
ajlm-786	45	29	ratios	ratio	NOUN
ajlm-786	45	30	of	of	ADP
ajlm-786	45	31	triglycerides	triglyceride	NOUN
ajlm-786	45	32	to	to	PART
ajlm-786	45	33	hdl	hdl	VERB
ajlm-786	45	34	cholesterol	cholesterol	NOUN
ajlm-786	45	35	(	(	PUNCT
ajlm-786	45	36	median	median	NOUN
ajlm-786	45	37	:	:	PUNCT
ajlm-786	45	38	1.89	1.89	NUM
ajlm-786	45	39	[	[	PUNCT
ajlm-786	45	40	iqr	iqr	X
ajlm-786	45	41	1.33–2.79	1.33–2.79	NUM
ajlm-786	45	42	]	]	PUNCT
ajlm-786	45	43	)	)	PUNCT
ajlm-786	45	44	compared	compare	VERB
ajlm-786	45	45	to	to	ADP
ajlm-786	45	46	t2	t2	PROPN
ajlm-786	45	47	dm	dm	PROPN
ajlm-786	45	48	patients	patient	NOUN
ajlm-786	45	49	with	with	ADP
ajlm-786	45	50	normal	normal	ADJ
ajlm-786	45	51	sua	sua	NOUN
ajlm-786	45	52	concentration	concentration	NOUN
ajlm-786	45	53	(	(	PUNCT
ajlm-786	45	54	median	median	NOUN
ajlm-786	45	55	:	:	PUNCT
ajlm-786	45	56	1.71	1.71	NUM
ajlm-786	45	57	[	[	X
ajlm-786	45	58	iqr	iqr	NOUN
ajlm-786	45	59	1.00–2.44	1.00–2.44	NOUN
ajlm-786	45	60	]	]	PUNCT
ajlm-786	45	61	,	,	PUNCT
ajlm-786	45	62	p	p	X
ajlm-786	45	63	=	=	PROPN
ajlm-786	45	64	0.021	0.021	NUM
ajlm-786	45	65	)	)	PUNCT
ajlm-786	45	66	.	.	PUNCT
ajlm-786	46	1	hyperuricaemia	hyperuricaemia	PROPN
ajlm-786	46	2	was	be	AUX
ajlm-786	46	3	associated	associate	VERB
ajlm-786	46	4	with	with	ADP
ajlm-786	46	5	higher	high	ADJ
ajlm-786	46	6	median	median	ADJ
ajlm-786	46	7	creatinine	creatinine	NOUN
ajlm-786	46	8	concentration	concentration	NOUN
ajlm-786	46	9	,	,	PUNCT
ajlm-786	46	10	78	78	NUM
ajlm-786	46	11	µmol	µmol	NOUN
ajlm-786	46	12	/	/	SYM
ajlm-786	46	13	l	l	NOUN
ajlm-786	46	14	(	(	PUNCT
ajlm-786	46	15	iqr	iqr	PROPN
ajlm-786	46	16	61–115	61–115	PROPN
ajlm-786	46	17	)	)	PUNCT
ajlm-786	46	18	vs	vs	ADP
ajlm-786	46	19	62	62	NUM
ajlm-786	46	20	µmol	µmol	NOUN
ajlm-786	46	21	/	/	SYM
ajlm-786	46	22	l	l	NOUN
ajlm-786	46	23	(	(	PUNCT
ajlm-786	46	24	iqr	iqr	X
ajlm-786	46	25	52–73	52–73	NUM
ajlm-786	46	26	)	)	PUNCT
ajlm-786	46	27	in	in	ADP
ajlm-786	46	28	patients	patient	NOUN
ajlm-786	46	29	with	with	ADP
ajlm-786	46	30	normal	normal	ADJ
ajlm-786	46	31	uric	uric	ADJ
ajlm-786	46	32	acid	acid	NOUN
ajlm-786	46	33	,	,	PUNCT
ajlm-786	46	34	p	p	X
ajlm-786	46	35	<	<	X
ajlm-786	46	36	0.001	0.001	NUM
ajlm-786	46	37	(	(	PUNCT
ajlm-786	46	38	figure	figure	NOUN
ajlm-786	46	39	1	1	NUM
ajlm-786	46	40	)	)	PUNCT
ajlm-786	46	41	.	.	PUNCT
ajlm-786	47	1	figure	figure	VERB
ajlm-786	47	2	1	1	NUM
ajlm-786	47	3	:	:	PUNCT
ajlm-786	47	4	comparison	comparison	NOUN
ajlm-786	47	5	of	of	ADP
ajlm-786	47	6	(	(	PUNCT
ajlm-786	47	7	a	a	X
ajlm-786	47	8	)	)	PUNCT
ajlm-786	47	9	serum	serum	NOUN
ajlm-786	47	10	creatinine	creatinine	NOUN
ajlm-786	47	11	concentration	concentration	NOUN
ajlm-786	47	12	and	and	CCONJ
ajlm-786	47	13	(	(	PUNCT
ajlm-786	47	14	b	b	NOUN
ajlm-786	47	15	)	)	PUNCT
ajlm-786	47	16	glycated	glycate	VERB
ajlm-786	47	17	haemoglobin	haemoglobin	NOUN
ajlm-786	47	18	(	(	PUNCT
ajlm-786	47	19	hba1c	hba1c	PROPN
ajlm-786	47	20	)	)	PUNCT
ajlm-786	47	21	according	accord	VERB
ajlm-786	47	22	to	to	ADP
ajlm-786	47	23	uric	uric	ADJ
ajlm-786	47	24	acid	acid	NOUN
ajlm-786	47	25	category	category	NOUN
ajlm-786	47	26	in	in	ADP
ajlm-786	47	27	type	type	NOUN
ajlm-786	47	28	2	2	NUM
ajlm-786	47	29	diabetes	diabetes	NOUN
ajlm-786	47	30	mellitus	mellitus	NOUN
ajlm-786	47	31	patients	patient	NOUN
ajlm-786	47	32	receiving	receive	VERB
ajlm-786	47	33	treatment	treatment	NOUN
ajlm-786	47	34	in	in	ADP
ajlm-786	47	35	gaborone	gaborone	PROPN
ajlm-786	47	36	,	,	PUNCT
ajlm-786	47	37	botswana	botswana	PROPN
ajlm-786	47	38	,	,	PUNCT
ajlm-786	47	39	september	september	PROPN
ajlm-786	47	40	–	–	PUNCT
ajlm-786	47	41	december	december	PROPN
ajlm-786	47	42	2016	2016	NUM
ajlm-786	47	43	.	.	PUNCT
ajlm-786	48	1	table	table	NOUN
ajlm-786	48	2	1	1	NUM
ajlm-786	48	3	:	:	PUNCT
ajlm-786	48	4	 	 	SPACE
ajlm-786	48	5	comparison	comparison	NOUN
ajlm-786	48	6	of	of	ADP
ajlm-786	48	7	laboratory	laboratory	NOUN
ajlm-786	48	8	characteristics	characteristic	NOUN
ajlm-786	48	9	according	accord	VERB
ajlm-786	48	10	to	to	ADP
ajlm-786	48	11	serum	serum	VERB
ajlm-786	48	12	uric	uric	ADJ
ajlm-786	48	13	acid	acid	NOUN
ajlm-786	48	14	categories	category	NOUN
ajlm-786	48	15	in	in	ADP
ajlm-786	48	16	type	type	NOUN
ajlm-786	48	17	2	2	NUM
ajlm-786	48	18	diabetes	diabetes	NOUN
ajlm-786	48	19	mellitus	mellitus	NOUN
ajlm-786	48	20	patients	patient	NOUN
ajlm-786	48	21	receiving	receive	VERB
ajlm-786	48	22	treatment	treatment	NOUN
ajlm-786	48	23	in	in	ADP
ajlm-786	48	24	gaborone	gaborone	PROPN
ajlm-786	48	25	,	,	PUNCT
ajlm-786	48	26	botswana	botswana	PROPN
ajlm-786	48	27	,	,	PUNCT
ajlm-786	48	28	september	september	PROPN
ajlm-786	48	29	–	–	PUNCT
ajlm-786	48	30	december	december	PROPN
ajlm-786	48	31	2016	2016	NUM
ajlm-786	48	32	.	.	PUNCT
ajlm-786	49	1	discussion	discussion	NOUN
ajlm-786	49	2	the	the	DET
ajlm-786	49	3	prevalence	prevalence	NOUN
ajlm-786	49	4	of	of	ADP
ajlm-786	49	5	hyperuricaemia	hyperuricaemia	NOUN
ajlm-786	49	6	among	among	ADP
ajlm-786	49	7	t2	t2	NOUN
ajlm-786	49	8	dm	dm	PROPN
ajlm-786	49	9	patients	patient	NOUN
ajlm-786	49	10	in	in	ADP
ajlm-786	49	11	botswana	botswana	PROPN
ajlm-786	49	12	is	be	AUX
ajlm-786	49	13	high	high	ADJ
ajlm-786	49	14	and	and	CCONJ
ajlm-786	49	15	is	be	AUX
ajlm-786	49	16	comparable	comparable	ADJ
ajlm-786	49	17	to	to	ADP
ajlm-786	49	18	findings	finding	NOUN
ajlm-786	49	19	in	in	ADP
ajlm-786	49	20	north	north	PROPN
ajlm-786	49	21	africa.15	africa.15	NOUN
ajlm-786	49	22	in	in	ADP
ajlm-786	49	23	our	our	PRON
ajlm-786	49	24	study	study	NOUN
ajlm-786	49	25	,	,	PUNCT
ajlm-786	49	26	hyperuricaemia	hyperuricaemia	PROPN
ajlm-786	49	27	was	be	AUX
ajlm-786	49	28	not	not	PART
ajlm-786	49	29	associated	associate	VERB
ajlm-786	49	30	with	with	ADP
ajlm-786	49	31	poor	poor	ADJ
ajlm-786	49	32	glycaemic	glycaemic	NOUN
ajlm-786	49	33	control	control	NOUN
ajlm-786	49	34	as	as	SCONJ
ajlm-786	49	35	measured	measure	VERB
ajlm-786	49	36	by	by	ADP
ajlm-786	49	37	hba1c	hba1c	PROPN
ajlm-786	49	38	.	.	PUNCT
ajlm-786	50	1	this	this	PRON
ajlm-786	50	2	is	be	AUX
ajlm-786	50	3	in	in	ADP
ajlm-786	50	4	contrast	contrast	NOUN
ajlm-786	50	5	to	to	ADP
ajlm-786	50	6	data	datum	NOUN
ajlm-786	50	7	from	from	ADP
ajlm-786	50	8	the	the	DET
ajlm-786	50	9	national	national	ADJ
ajlm-786	50	10	health	health	PROPN
ajlm-786	50	11	and	and	CCONJ
ajlm-786	50	12	nutrition	nutrition	NOUN
ajlm-786	50	13	examination	examination	NOUN
ajlm-786	50	14	survey	survey	NOUN
ajlm-786	50	15	iii	iii	NUM
ajlm-786	50	16	conducted	conduct	VERB
ajlm-786	50	17	nationwide	nationwide	ADV
ajlm-786	50	18	in	in	ADP
ajlm-786	50	19	the	the	DET
ajlm-786	50	20	united	united	PROPN
ajlm-786	50	21	states.16	states.16	PROPN
ajlm-786	50	22	our	our	PRON
ajlm-786	50	23	data	datum	NOUN
ajlm-786	50	24	corroborates	corroborate	VERB
ajlm-786	50	25	findings	finding	NOUN
ajlm-786	50	26	from	from	ADP
ajlm-786	50	27	another	another	DET
ajlm-786	50	28	study	study	NOUN
ajlm-786	50	29	conducted	conduct	VERB
ajlm-786	50	30	on	on	ADP
ajlm-786	50	31	a	a	DET
ajlm-786	50	32	cohort	cohort	NOUN
ajlm-786	50	33	of	of	ADP
ajlm-786	50	34	newly	newly	ADV
ajlm-786	50	35	diagnosed	diagnose	VERB
ajlm-786	50	36	t2	t2	NOUN
ajlm-786	51	1	dm	dm	PROPN
ajlm-786	51	2	patients	patient	NOUN
ajlm-786	51	3	in	in	ADP
ajlm-786	51	4	china	china	PROPN
ajlm-786	51	5	that	that	PRON
ajlm-786	51	6	reported	report	VERB
ajlm-786	51	7	no	no	DET
ajlm-786	51	8	relationship	relationship	NOUN
ajlm-786	51	9	between	between	ADP
ajlm-786	51	10	sua	sua	NOUN
ajlm-786	51	11	and	and	CCONJ
ajlm-786	51	12	hba1c	hba1c	NOUN
ajlm-786	51	13	after	after	ADP
ajlm-786	51	14	adjusting	adjust	VERB
ajlm-786	51	15	for	for	ADP
ajlm-786	51	16	insulin	insulin	NOUN
ajlm-786	51	17	concentration.17	concentration.17	PROPN
ajlm-786	51	18	lipids	lipid	NOUN
ajlm-786	51	19	are	be	AUX
ajlm-786	51	20	a	a	DET
ajlm-786	51	21	risk	risk	NOUN
ajlm-786	51	22	factor	factor	NOUN
ajlm-786	51	23	for	for	ADP
ajlm-786	51	24	cardiovascular	cardiovascular	ADJ
ajlm-786	51	25	disease.13	disease.13	NOUN
ajlm-786	51	26	in	in	ADP
ajlm-786	51	27	our	our	PRON
ajlm-786	51	28	study	study	NOUN
ajlm-786	51	29	,	,	PUNCT
ajlm-786	51	30	t2	t2	NOUN
ajlm-786	51	31	dm	dm	PROPN
ajlm-786	51	32	patients	patient	NOUN
ajlm-786	51	33	with	with	ADP
ajlm-786	51	34	hyperuricaemia	hyperuricaemia	NOUN
ajlm-786	51	35	had	have	VERB
ajlm-786	51	36	significantly	significantly	ADV
ajlm-786	51	37	higher	high	ADJ
ajlm-786	51	38	triglyceride	triglyceride	ADP
ajlm-786	51	39	concentrations	concentration	NOUN
ajlm-786	51	40	and	and	CCONJ
ajlm-786	51	41	triglyceride	triglyceride	ADJ
ajlm-786	51	42	to	to	ADP
ajlm-786	51	43	hdl	hdl	PROPN
ajlm-786	51	44	cholesterol	cholesterol	PROPN
ajlm-786	51	45	ratios	ratio	NOUN
ajlm-786	51	46	.	.	PUNCT
ajlm-786	52	1	it	it	PRON
ajlm-786	52	2	has	have	AUX
ajlm-786	52	3	been	be	AUX
ajlm-786	52	4	suggested	suggest	VERB
ajlm-786	52	5	that	that	SCONJ
ajlm-786	52	6	a	a	DET
ajlm-786	52	7	high	high	ADJ
ajlm-786	52	8	triglyceride	triglyceride	NOUN
ajlm-786	52	9	to	to	ADP
ajlm-786	52	10	hdl	hdl	PROPN
ajlm-786	52	11	cholesterol	cholesterol	PROPN
ajlm-786	52	12	ratio	ratio	NOUN
ajlm-786	52	13	is	be	AUX
ajlm-786	52	14	a	a	DET
ajlm-786	52	15	risk	risk	NOUN
ajlm-786	52	16	factor	factor	NOUN
ajlm-786	52	17	for	for	ADP
ajlm-786	52	18	coronary	coronary	ADJ
ajlm-786	52	19	heart	heart	NOUN
ajlm-786	52	20	disease.18	disease.18	VERB
ajlm-786	52	21	the	the	DET
ajlm-786	52	22	triglyceride	triglyceride	NOUN
ajlm-786	52	23	to	to	PART
ajlm-786	52	24	hdl	hdl	PROPN
ajlm-786	52	25	cholesterol	cholesterol	PROPN
ajlm-786	52	26	ratio	ratio	NOUN
ajlm-786	52	27	can	can	AUX
ajlm-786	52	28	be	be	AUX
ajlm-786	52	29	used	use	VERB
ajlm-786	52	30	to	to	PART
ajlm-786	52	31	predict	predict	VERB
ajlm-786	52	32	the	the	DET
ajlm-786	52	33	presence	presence	NOUN
ajlm-786	52	34	and	and	CCONJ
ajlm-786	52	35	degree	degree	NOUN
ajlm-786	52	36	of	of	ADP
ajlm-786	52	37	coronary	coronary	ADJ
ajlm-786	52	38	atherosclerosis.19	atherosclerosis.19	NOUN
ajlm-786	52	39	although	although	SCONJ
ajlm-786	52	40	high	high	ADJ
ajlm-786	52	41	triglyceride	triglyceride	ADV
ajlm-786	52	42	to	to	ADP
ajlm-786	52	43	hdl	hdl	PROPN
ajlm-786	52	44	cholesterol	cholesterol	PROPN
ajlm-786	52	45	ratio	ratio	NOUN
ajlm-786	52	46	has	have	AUX
ajlm-786	52	47	been	be	AUX
ajlm-786	52	48	reported	report	VERB
ajlm-786	52	49	to	to	PART
ajlm-786	52	50	be	be	AUX
ajlm-786	52	51	a	a	DET
ajlm-786	52	52	marker	marker	NOUN
ajlm-786	52	53	of	of	ADP
ajlm-786	52	54	insulin	insulin	NOUN
ajlm-786	52	55	resistance,20	resistance,20	NOUN
ajlm-786	52	56	a	a	DET
ajlm-786	52	57	study	study	NOUN
ajlm-786	52	58	of	of	ADP
ajlm-786	52	59	african	african	ADJ
ajlm-786	52	60	americans	americans	PROPN
ajlm-786	52	61	did	do	AUX
ajlm-786	52	62	not	not	PART
ajlm-786	52	63	corroborate	corroborate	VERB
ajlm-786	52	64	this	this	DET
ajlm-786	52	65	finding.21	finding.21	NOUN
ajlm-786	52	66	other	other	ADJ
ajlm-786	52	67	lipids	lipid	NOUN
ajlm-786	52	68	were	be	AUX
ajlm-786	52	69	not	not	PART
ajlm-786	52	70	associated	associate	VERB
ajlm-786	52	71	with	with	ADP
ajlm-786	52	72	hyperuricaemia	hyperuricaemia	NOUN
ajlm-786	52	73	in	in	ADP
ajlm-786	52	74	our	our	PRON
ajlm-786	52	75	study	study	NOUN
ajlm-786	52	76	.	.	PUNCT
ajlm-786	53	1	hyperuricaemia	hyperuricaemia	PROPN
ajlm-786	53	2	was	be	AUX
ajlm-786	53	3	associated	associate	VERB
ajlm-786	53	4	with	with	ADP
ajlm-786	53	5	an	an	DET
ajlm-786	53	6	increased	increase	VERB
ajlm-786	53	7	creatinine	creatinine	NOUN
ajlm-786	53	8	concentration	concentration	NOUN
ajlm-786	53	9	.	.	PUNCT
ajlm-786	54	1	although	although	SCONJ
ajlm-786	54	2	hyperuricaemia	hyperuricaemia	NOUN
ajlm-786	54	3	may	may	AUX
ajlm-786	54	4	simply	simply	ADV
ajlm-786	54	5	be	be	AUX
ajlm-786	54	6	a	a	DET
ajlm-786	54	7	marker	marker	NOUN
ajlm-786	54	8	of	of	ADP
ajlm-786	54	9	renal	renal	ADJ
ajlm-786	54	10	disease	disease	NOUN
ajlm-786	54	11	,	,	PUNCT
ajlm-786	54	12	there	there	PRON
ajlm-786	54	13	are	be	VERB
ajlm-786	54	14	studies	study	NOUN
ajlm-786	54	15	which	which	PRON
ajlm-786	54	16	suggest	suggest	VERB
ajlm-786	54	17	that	that	SCONJ
ajlm-786	54	18	elevated	elevated	ADJ
ajlm-786	54	19	sua	sua	NOUN
ajlm-786	54	20	levels	level	NOUN
ajlm-786	54	21	might	might	AUX
ajlm-786	54	22	contribute	contribute	VERB
ajlm-786	54	23	to	to	ADP
ajlm-786	54	24	the	the	DET
ajlm-786	54	25	development	development	NOUN
ajlm-786	54	26	and	and	CCONJ
ajlm-786	54	27	progression	progression	NOUN
ajlm-786	54	28	of	of	ADP
ajlm-786	54	29	renal	renal	PROPN
ajlm-786	54	30	dysfunction.3	dysfunction.3	PROPN
ajlm-786	54	31	recently	recently	ADV
ajlm-786	54	32	(	(	PUNCT
ajlm-786	54	33	2014	2014	NUM
ajlm-786	54	34	)	)	PUNCT
ajlm-786	54	35	,	,	PUNCT
ajlm-786	54	36	toda	toda	PROPN
ajlm-786	54	37	et	et	PROPN
ajlm-786	54	38	al	al	PROPN
ajlm-786	54	39	.	.	PROPN
ajlm-786	54	40	reported	report	VERB
ajlm-786	54	41	that	that	SCONJ
ajlm-786	54	42	hyperuricaemia	hyperuricaemia	PROPN
ajlm-786	54	43	was	be	AUX
ajlm-786	54	44	an	an	DET
ajlm-786	54	45	independent	independent	ADJ
ajlm-786	54	46	risk	risk	NOUN
ajlm-786	54	47	factor	factor	NOUN
ajlm-786	54	48	for	for	ADP
ajlm-786	54	49	the	the	DET
ajlm-786	54	50	development	development	NOUN
ajlm-786	54	51	of	of	ADP
ajlm-786	54	52	chronic	chronic	ADJ
ajlm-786	54	53	kidney	kidney	PROPN
ajlm-786	54	54	disease,22	disease,22	NOUN
ajlm-786	54	55	and	and	CCONJ
ajlm-786	54	56	in	in	ADP
ajlm-786	54	57	studies	study	NOUN
ajlm-786	54	58	in	in	ADP
ajlm-786	54	59	japan	japan	PROPN
ajlm-786	54	60	,	,	PUNCT
ajlm-786	54	61	elevated	elevated	ADJ
ajlm-786	54	62	baseline	baseline	NOUN
ajlm-786	54	63	sua	sua	NOUN
ajlm-786	54	64	and	and	CCONJ
ajlm-786	54	65	increases	increase	NOUN
ajlm-786	54	66	in	in	ADP
ajlm-786	54	67	sua	sua	PROPN
ajlm-786	54	68	increased	increase	VERB
ajlm-786	54	69	the	the	DET
ajlm-786	54	70	risk	risk	NOUN
ajlm-786	54	71	of	of	ADP
ajlm-786	54	72	developing	develop	VERB
ajlm-786	54	73	chronic	chronic	ADJ
ajlm-786	54	74	kidney	kidney	NOUN
ajlm-786	54	75	disease.23	disease.23	VERB
ajlm-786	54	76	in	in	ADP
ajlm-786	54	77	another	another	DET
ajlm-786	54	78	study	study	NOUN
ajlm-786	54	79	,	,	PUNCT
ajlm-786	54	80	hyperuricaemia	hyperuricaemia	PROPN
ajlm-786	54	81	was	be	AUX
ajlm-786	54	82	associated	associate	VERB
ajlm-786	54	83	with	with	ADP
ajlm-786	54	84	incident	incident	NOUN
ajlm-786	54	85	diabetic	diabetic	ADJ
ajlm-786	54	86	retinopathy	retinopathy	NOUN
ajlm-786	54	87	among	among	ADP
ajlm-786	54	88	male	male	ADJ
ajlm-786	54	89	patients	patient	NOUN
ajlm-786	54	90	with	with	ADP
ajlm-786	54	91	t2dm.24	t2dm.24	NOUN
ajlm-786	54	92	limitations	limitation	NOUN
ajlm-786	54	93	we	we	PRON
ajlm-786	54	94	acknowledge	acknowledge	VERB
ajlm-786	54	95	that	that	SCONJ
ajlm-786	54	96	missing	miss	VERB
ajlm-786	54	97	data	datum	NOUN
ajlm-786	54	98	on	on	ADP
ajlm-786	54	99	dm	dm	PROPN
ajlm-786	54	100	duration	duration	NOUN
ajlm-786	54	101	is	be	AUX
ajlm-786	54	102	a	a	DET
ajlm-786	54	103	limitation	limitation	NOUN
ajlm-786	54	104	to	to	ADP
ajlm-786	54	105	the	the	DET
ajlm-786	54	106	interpretation	interpretation	NOUN
ajlm-786	54	107	of	of	ADP
ajlm-786	54	108	our	our	PRON
ajlm-786	54	109	findings	finding	NOUN
ajlm-786	54	110	,	,	PUNCT
ajlm-786	54	111	as	as	SCONJ
ajlm-786	54	112	the	the	DET
ajlm-786	54	113	evolution	evolution	NOUN
ajlm-786	54	114	of	of	ADP
ajlm-786	54	115	nephropathy	nephropathy	NOUN
ajlm-786	54	116	and	and	CCONJ
ajlm-786	54	117	microvascular	microvascular	ADJ
ajlm-786	54	118	diseases	disease	NOUN
ajlm-786	54	119	may	may	AUX
ajlm-786	54	120	be	be	AUX
ajlm-786	54	121	influenced	influence	VERB
ajlm-786	54	122	by	by	ADP
ajlm-786	54	123	the	the	DET
ajlm-786	54	124	duration	duration	NOUN
ajlm-786	54	125	of	of	ADP
ajlm-786	54	126	dm	dm	PROPN
ajlm-786	54	127	.	.	PUNCT
ajlm-786	55	1	adjusting	adjust	VERB
ajlm-786	55	2	for	for	ADP
ajlm-786	55	3	the	the	DET
ajlm-786	55	4	duration	duration	NOUN
ajlm-786	55	5	of	of	ADP
ajlm-786	55	6	t2	t2	PROPN
ajlm-786	55	7	dm	dm	PROPN
ajlm-786	55	8	and	and	CCONJ
ajlm-786	55	9	the	the	DET
ajlm-786	55	10	severity	severity	NOUN
ajlm-786	55	11	of	of	ADP
ajlm-786	55	12	dm	dm	PRON
ajlm-786	55	13	might	might	AUX
ajlm-786	55	14	have	have	AUX
ajlm-786	55	15	sharpened	sharpen	VERB
ajlm-786	55	16	our	our	PRON
ajlm-786	55	17	findings	finding	NOUN
ajlm-786	55	18	.	.	PUNCT
ajlm-786	56	1	in	in	ADP
ajlm-786	56	2	a	a	DET
ajlm-786	56	3	study	study	NOUN
ajlm-786	56	4	by	by	ADP
ajlm-786	56	5	korpachev	korpachev	PROPN
ajlm-786	56	6	et	et	PROPN
ajlm-786	56	7	al	al	PROPN
ajlm-786	56	8	.	.	PROPN
ajlm-786	56	9	in	in	ADP
ajlm-786	56	10	2009	2009	NUM
ajlm-786	56	11	,	,	PUNCT
ajlm-786	56	12	hyperuricaemia	hyperuricaemia	NOUN
ajlm-786	56	13	with	with	ADP
ajlm-786	56	14	decreased	decrease	VERB
ajlm-786	56	15	uric	uric	ADJ
ajlm-786	56	16	acid	acid	NOUN
ajlm-786	56	17	excretion	excretion	NOUN
ajlm-786	56	18	was	be	AUX
ajlm-786	56	19	characteristic	characteristic	ADJ
ajlm-786	56	20	of	of	ADP
ajlm-786	56	21	severe	severe	ADJ
ajlm-786	56	22	dm	dm	NOUN
ajlm-786	56	23	,	,	PUNCT
ajlm-786	56	24	with	with	ADP
ajlm-786	56	25	a	a	DET
ajlm-786	56	26	reduced	reduce	VERB
ajlm-786	56	27	kidney	kidney	NOUN
ajlm-786	56	28	filtration	filtration	NOUN
ajlm-786	56	29	rate.25	rate.25	NOUN
ajlm-786	56	30	conditions	condition	NOUN
ajlm-786	56	31	that	that	PRON
ajlm-786	56	32	reduce	reduce	VERB
ajlm-786	56	33	erythrocyte	erythrocyte	NOUN
ajlm-786	56	34	survival	survival	NOUN
ajlm-786	56	35	time	time	NOUN
ajlm-786	56	36	may	may	AUX
ajlm-786	56	37	affect	affect	VERB
ajlm-786	56	38	hba1c	hba1c	ADJ
ajlm-786	56	39	values	value	NOUN
ajlm-786	56	40	.	.	PUNCT
ajlm-786	57	1	although	although	SCONJ
ajlm-786	57	2	we	we	PRON
ajlm-786	57	3	did	do	AUX
ajlm-786	57	4	not	not	PART
ajlm-786	57	5	screen	screen	VERB
ajlm-786	57	6	for	for	ADP
ajlm-786	57	7	the	the	DET
ajlm-786	57	8	effect	effect	NOUN
ajlm-786	57	9	of	of	ADP
ajlm-786	57	10	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-786	57	11	or	or	CCONJ
ajlm-786	57	12	malaria	malaria	NOUN
ajlm-786	57	13	on	on	ADP
ajlm-786	57	14	hba1c	hba1c	PROPN
ajlm-786	57	15	,	,	PUNCT
ajlm-786	57	16	it	it	PRON
ajlm-786	57	17	is	be	AUX
ajlm-786	57	18	unlikely	unlikely	ADJ
ajlm-786	57	19	that	that	SCONJ
ajlm-786	57	20	these	these	DET
ajlm-786	57	21	conditions	condition	NOUN
ajlm-786	57	22	were	be	AUX
ajlm-786	57	23	confounders	confounder	NOUN
ajlm-786	57	24	in	in	ADP
ajlm-786	57	25	our	our	PRON
ajlm-786	57	26	study	study	NOUN
ajlm-786	57	27	.	.	PUNCT
ajlm-786	58	1	malaria	malaria	NOUN
ajlm-786	58	2	transmission	transmission	NOUN
ajlm-786	58	3	in	in	ADP
ajlm-786	58	4	southern	southern	ADJ
ajlm-786	58	5	botswana	botswana	PROPN
ajlm-786	58	6	is	be	AUX
ajlm-786	58	7	low	low	ADJ
ajlm-786	58	8	to	to	PART
ajlm-786	58	9	absent	absent	VERB
ajlm-786	58	10	,	,	PUNCT
ajlm-786	58	11	and	and	CCONJ
ajlm-786	58	12	there	there	PRON
ajlm-786	58	13	is	be	VERB
ajlm-786	58	14	no	no	DET
ajlm-786	58	15	literature	literature	NOUN
ajlm-786	58	16	on	on	ADP
ajlm-786	58	17	haemoglobinopathy	haemoglobinopathy	ADJ
ajlm-786	58	18	in	in	ADP
ajlm-786	58	19	botswana	botswana	PROPN
ajlm-786	58	20	.	.	PUNCT
ajlm-786	59	1	conclusion	conclusion	NOUN
ajlm-786	59	2	in	in	ADP
ajlm-786	59	3	conclusion	conclusion	NOUN
ajlm-786	59	4	,	,	PUNCT
ajlm-786	59	5	hyperuricaemia	hyperuricaemia	PROPN
ajlm-786	59	6	was	be	AUX
ajlm-786	59	7	prevalent	prevalent	ADJ
ajlm-786	59	8	among	among	ADP
ajlm-786	59	9	t2	t2	NOUN
ajlm-786	59	10	dm	dm	NUM
ajlm-786	59	11	patients	patient	NOUN
ajlm-786	59	12	in	in	ADP
ajlm-786	59	13	our	our	PRON
ajlm-786	59	14	study	study	NOUN
ajlm-786	59	15	and	and	CCONJ
ajlm-786	59	16	was	be	AUX
ajlm-786	59	17	associated	associate	VERB
ajlm-786	59	18	with	with	ADP
ajlm-786	59	19	elevated	elevated	ADJ
ajlm-786	59	20	triglyceride	triglyceride	ADJ
ajlm-786	59	21	concentrations	concentration	NOUN
ajlm-786	59	22	,	,	PUNCT
ajlm-786	59	23	a	a	DET
ajlm-786	59	24	high	high	ADJ
ajlm-786	59	25	triglyceride	triglyceride	NOUN
ajlm-786	59	26	to	to	ADP
ajlm-786	59	27	hdl	hdl	PROPN
ajlm-786	59	28	cholesterol	cholesterol	PROPN
ajlm-786	59	29	ratio	ratio	NOUN
ajlm-786	59	30	and	and	CCONJ
ajlm-786	59	31	elevated	elevated	ADJ
ajlm-786	59	32	serum	serum	NOUN
ajlm-786	59	33	creatinine	creatinine	NOUN
ajlm-786	59	34	concentration	concentration	NOUN
ajlm-786	59	35	,	,	PUNCT
ajlm-786	59	36	but	but	CCONJ
ajlm-786	59	37	it	it	PRON
ajlm-786	59	38	was	be	AUX
ajlm-786	59	39	not	not	PART
ajlm-786	59	40	associated	associate	VERB
ajlm-786	59	41	with	with	ADP
ajlm-786	59	42	hba1c	hba1c	PROPN
ajlm-786	59	43	concentration	concentration	NOUN
ajlm-786	59	44	.	.	PUNCT
ajlm-786	60	1	as	as	SCONJ
ajlm-786	60	2	recommended	recommend	VERB
ajlm-786	60	3	elsewhere	elsewhere	ADV
ajlm-786	60	4	,	,	PUNCT
ajlm-786	60	5	the	the	DET
ajlm-786	60	6	monitoring	monitoring	NOUN
ajlm-786	60	7	of	of	ADP
ajlm-786	60	8	t2	t2	NOUN
ajlm-786	60	9	dm	dm	PROPN
ajlm-786	60	10	should	should	AUX
ajlm-786	60	11	include	include	VERB
ajlm-786	60	12	the	the	DET
ajlm-786	60	13	measurement	measurement	NOUN
ajlm-786	60	14	of	of	ADP
ajlm-786	60	15	sua	sua	PROPN
ajlm-786	60	16	and	and	CCONJ
ajlm-786	60	17	the	the	DET
ajlm-786	60	18	institution	institution	NOUN
ajlm-786	60	19	of	of	ADP
ajlm-786	60	20	interventions	intervention	NOUN
ajlm-786	60	21	that	that	PRON
ajlm-786	60	22	lower	low	ADJ
ajlm-786	60	23	sua.3	sua.3	NOUN
ajlm-786	60	24	acknowledgements	acknowledgement	NOUN
ajlm-786	60	25	we	we	PRON
ajlm-786	60	26	would	would	AUX
ajlm-786	60	27	like	like	VERB
ajlm-786	60	28	to	to	PART
ajlm-786	60	29	thank	thank	VERB
ajlm-786	60	30	the	the	DET
ajlm-786	60	31	laboratory	laboratory	NOUN
ajlm-786	60	32	staff	staff	NOUN
ajlm-786	60	33	of	of	ADP
ajlm-786	60	34	the	the	DET
ajlm-786	60	35	national	national	PROPN
ajlm-786	60	36	health	health	PROPN
ajlm-786	60	37	laboratory	laboratory	PROPN
ajlm-786	60	38	service	service	NOUN
ajlm-786	60	39	and	and	CCONJ
ajlm-786	60	40	lancet	lancet	NOUN
ajlm-786	60	41	laboratories	laboratory	NOUN
ajlm-786	60	42	for	for	ADP
ajlm-786	60	43	providing	provide	VERB
ajlm-786	60	44	the	the	DET
ajlm-786	60	45	serological	serological	ADJ
ajlm-786	60	46	and	and	CCONJ
ajlm-786	60	47	molecular	molecular	ADJ
ajlm-786	60	48	testing	testing	NOUN
ajlm-786	60	49	.	.	PUNCT
ajlm-786	61	1	competing	compete	VERB
ajlm-786	61	2	interests	interest	NOUN
ajlm-786	61	3	the	the	DET
ajlm-786	61	4	authors	author	NOUN
ajlm-786	61	5	have	have	AUX
ajlm-786	61	6	declared	declare	VERB
ajlm-786	61	7	that	that	SCONJ
ajlm-786	61	8	no	no	DET
ajlm-786	61	9	competing	compete	VERB
ajlm-786	61	10	interests	interest	NOUN
ajlm-786	61	11	exist	exist	VERB
ajlm-786	61	12	.	.	PUNCT
ajlm-786	62	1	authors	author	NOUN
ajlm-786	62	2	’	’	PART
ajlm-786	62	3	contributions	contribution	NOUN
ajlm-786	62	4	e.g.	e.g.	ADV
ajlm-786	62	5	and	and	CCONJ
ajlm-786	62	6	i.k	i.k	PROPN
ajlm-786	62	7	.	.	PROPN
ajlm-786	62	8	were	be	AUX
ajlm-786	62	9	responsible	responsible	ADJ
ajlm-786	62	10	for	for	ADP
ajlm-786	62	11	the	the	DET
ajlm-786	62	12	conceptualisation	conceptualisation	NOUN
ajlm-786	62	13	,	,	PUNCT
ajlm-786	62	14	experimental	experimental	ADJ
ajlm-786	62	15	design	design	NOUN
ajlm-786	62	16	,	,	PUNCT
ajlm-786	62	17	data	data	NOUN
ajlm-786	62	18	acquisition	acquisition	NOUN
ajlm-786	62	19	,	,	PUNCT
ajlm-786	62	20	analysis	analysis	NOUN
ajlm-786	62	21	,	,	PUNCT
ajlm-786	62	22	interpretation	interpretation	NOUN
ajlm-786	62	23	of	of	ADP
ajlm-786	62	24	data	datum	NOUN
ajlm-786	62	25	and	and	CCONJ
ajlm-786	62	26	writing	writing	NOUN
ajlm-786	62	27	of	of	ADP
ajlm-786	62	28	the	the	DET
ajlm-786	62	29	manuscript	manuscript	NOUN
ajlm-786	62	30	.	.	PUNCT
ajlm-786	63	1	n.g.n	n.g.n	PROPN
ajlm-786	63	2	.	.	PROPN
ajlm-786	63	3	and	and	CCONJ
ajlm-786	63	4	m.s.m	m.s.m	PROPN
ajlm-786	63	5	.	.	PROPN
ajlm-786	63	6	contributed	contribute	VERB
ajlm-786	63	7	to	to	ADP
ajlm-786	63	8	the	the	DET
ajlm-786	63	9	experimental	experimental	ADJ
ajlm-786	63	10	design	design	NOUN
ajlm-786	63	11	and	and	CCONJ
ajlm-786	63	12	revising	revise	VERB
ajlm-786	63	13	the	the	DET
ajlm-786	63	14	manuscript	manuscript	NOUN
ajlm-786	63	15	for	for	ADP
ajlm-786	63	16	important	important	ADJ
ajlm-786	63	17	intellectual	intellectual	ADJ
ajlm-786	63	18	content	content	NOUN
ajlm-786	63	19	.	.	PUNCT
ajlm-786	64	1	all	all	DET
ajlm-786	64	2	authors	author	NOUN
ajlm-786	64	3	read	read	VERB
ajlm-786	64	4	and	and	CCONJ
ajlm-786	64	5	approved	approve	VERB
ajlm-786	64	6	the	the	DET
ajlm-786	64	7	final	final	ADJ
ajlm-786	64	8	manuscript	manuscript	NOUN
ajlm-786	64	9	.	.	PUNCT
ajlm-786	65	1	sources	source	NOUN
ajlm-786	65	2	of	of	ADP
ajlm-786	65	3	support	support	NOUN
ajlm-786	65	4	this	this	DET
ajlm-786	65	5	research	research	NOUN
ajlm-786	65	6	did	do	AUX
ajlm-786	65	7	not	not	PART
ajlm-786	65	8	receive	receive	VERB
ajlm-786	65	9	any	any	DET
ajlm-786	65	10	specific	specific	ADJ
ajlm-786	65	11	grant	grant	NOUN
ajlm-786	65	12	from	from	ADP
ajlm-786	65	13	funding	fund	VERB
ajlm-786	65	14	agencies	agency	NOUN
ajlm-786	65	15	in	in	ADP
ajlm-786	65	16	the	the	DET
ajlm-786	65	17	public	public	ADJ
ajlm-786	65	18	,	,	PUNCT
ajlm-786	65	19	commercial	commercial	ADJ
ajlm-786	65	20	or	or	CCONJ
ajlm-786	65	21	not	not	PART
ajlm-786	65	22	-	-	PUNCT
ajlm-786	65	23	for	for	ADP
ajlm-786	65	24	-	-	PUNCT
ajlm-786	65	25	profit	profit	NOUN
ajlm-786	65	26	sectors	sector	NOUN
ajlm-786	65	27	.	.	PUNCT
ajlm-786	66	1	data	datum	NOUN
ajlm-786	66	2	availability	availability	NOUN
ajlm-786	66	3	statement	statement	NOUN
ajlm-786	66	4	data	datum	NOUN
ajlm-786	66	5	sharing	sharing	NOUN
ajlm-786	66	6	is	be	AUX
ajlm-786	66	7	not	not	PART
ajlm-786	66	8	applicable	applicable	ADJ
ajlm-786	66	9	to	to	ADP
ajlm-786	66	10	this	this	DET
ajlm-786	66	11	article	article	NOUN
ajlm-786	66	12	as	as	SCONJ
ajlm-786	66	13	no	no	DET
ajlm-786	66	14	new	new	ADJ
ajlm-786	66	15	data	datum	NOUN
ajlm-786	66	16	were	be	AUX
ajlm-786	66	17	created	create	VERB
ajlm-786	66	18	or	or	CCONJ
ajlm-786	66	19	analysed	analyse	VERB
ajlm-786	66	20	in	in	ADP
ajlm-786	66	21	this	this	DET
ajlm-786	66	22	study	study	NOUN
ajlm-786	66	23	.	.	PUNCT
ajlm-786	67	1	disclaimer	disclaimer	VERB
ajlm-786	67	2	the	the	DET
ajlm-786	67	3	views	view	NOUN
ajlm-786	67	4	and	and	CCONJ
ajlm-786	67	5	opinions	opinion	NOUN
ajlm-786	67	6	expressed	express	VERB
ajlm-786	67	7	in	in	ADP
ajlm-786	67	8	this	this	DET
ajlm-786	67	9	article	article	NOUN
ajlm-786	67	10	are	be	AUX
ajlm-786	67	11	those	those	PRON
ajlm-786	67	12	of	of	ADP
ajlm-786	67	13	the	the	DET
ajlm-786	67	14	authors	author	NOUN
ajlm-786	67	15	and	and	CCONJ
ajlm-786	67	16	do	do	AUX
ajlm-786	67	17	not	not	PART
ajlm-786	67	18	necessarily	necessarily	ADV
ajlm-786	67	19	reflect	reflect	VERB
ajlm-786	67	20	the	the	DET
ajlm-786	67	21	official	official	ADJ
ajlm-786	67	22	policy	policy	NOUN
ajlm-786	67	23	or	or	CCONJ
ajlm-786	67	24	position	position	NOUN
ajlm-786	67	25	of	of	ADP
ajlm-786	67	26	any	any	DET
ajlm-786	67	27	affiliated	affiliated	ADJ
ajlm-786	67	28	agency	agency	NOUN
ajlm-786	67	29	of	of	ADP
ajlm-786	67	30	the	the	DET
ajlm-786	67	31	authors	author	NOUN
ajlm-786	67	32	.	.	PUNCT
ajlm-786	68	1	references	reference	NOUN
ajlm-786	68	2	kivity	kivity	PROPN
ajlm-786	68	3	s	s	PROPN
ajlm-786	68	4	,	,	PUNCT
ajlm-786	68	5	kopel	kopel	PROPN
ajlm-786	68	6	e	e	PROPN
ajlm-786	68	7	,	,	PUNCT
ajlm-786	68	8	steinlauf	steinlauf	PROPN
ajlm-786	68	9	s	s	PROPN
ajlm-786	68	10	,	,	PUNCT
ajlm-786	68	11	et	et	PROPN
ajlm-786	68	12	al	al	PROPN
ajlm-786	68	13	.	.	PUNCT
ajlm-786	69	1	the	the	DET
ajlm-786	69	2	association	association	NOUN
ajlm-786	69	3	between	between	ADP
ajlm-786	69	4	serum	serum	PROPN
ajlm-786	69	5	uric	uric	ADJ
ajlm-786	69	6	acid	acid	NOUN
ajlm-786	69	7	and	and	CCONJ
ajlm-786	69	8	diabetes	diabetes	NOUN
ajlm-786	69	9	mellitus	mellitus	NOUN
ajlm-786	69	10	is	be	AUX
ajlm-786	69	11	stronger	strong	ADJ
ajlm-786	69	12	in	in	ADP
ajlm-786	69	13	women	woman	NOUN
ajlm-786	69	14	.	.	PUNCT
ajlm-786	70	1	j	j	PROPN
ajlm-786	70	2	women	women	PROPN
ajlm-786	70	3	health	health	PROPN
ajlm-786	70	4	.	.	PUNCT
ajlm-786	71	1	2013	2013	NUM
ajlm-786	71	2	;	;	PUNCT
ajlm-786	71	3	22(9):782–789	22(9):782–789	ADJ
ajlm-786	71	4	.	.	PUNCT
ajlm-786	72	1	https://doi.org/10.1089/jwh.2012.4043	https://doi.org/10.1089/jwh.2012.4043	NOUN
ajlm-786	72	2	freedman	freedman	PROPN
ajlm-786	72	3	ds	ds	PROPN
ajlm-786	72	4	,	,	PUNCT
ajlm-786	72	5	williamson	williamson	PROPN
ajlm-786	72	6	df	df	PROPN
ajlm-786	72	7	,	,	PUNCT
ajlm-786	72	8	gunter	gunter	PROPN
ajlm-786	72	9	ew	ew	PROPN
ajlm-786	72	10	,	,	PUNCT
ajlm-786	72	11	et	et	PROPN
ajlm-786	72	12	al	al	PROPN
ajlm-786	72	13	.	.	PUNCT
ajlm-786	72	14	relation	relation	NOUN
ajlm-786	72	15	of	of	ADP
ajlm-786	72	16	serum	serum	PROPN
ajlm-786	72	17	uric	uric	ADJ
ajlm-786	72	18	acid	acid	NOUN
ajlm-786	72	19	to	to	ADP
ajlm-786	72	20	mortality	mortality	NOUN
ajlm-786	72	21	and	and	CCONJ
ajlm-786	72	22	heart	heart	NOUN
ajlm-786	72	23	disease	disease	NOUN
ajlm-786	72	24	.	.	PUNCT
ajlm-786	73	1	the	the	DET
ajlm-786	73	2	nhanes	nhane	NOUN
ajlm-786	73	3	i	i	PRON
ajlm-786	73	4	epidemiologic	epidemiologic	ADJ
ajlm-786	73	5	follow	follow	VERB
ajlm-786	73	6	-	-	PUNCT
ajlm-786	73	7	up	up	ADP
ajlm-786	73	8	study	study	NOUN
ajlm-786	73	9	.	.	PUNCT
ajlm-786	74	1	am	be	AUX
ajlm-786	74	2	j	j	PROPN
ajlm-786	74	3	epidemiol	epidemiol	PROPN
ajlm-786	74	4	.	.	PUNCT
ajlm-786	75	1	1995;141:637–644	1995;141:637–644	NUM
ajlm-786	75	2	.	.	PUNCT
ajlm-786	76	1	https://doi.org/10.1093/oxfordjournals.aje.a117479	https://doi.org/10.1093/oxfordjournals.aje.a117479	PROPN
ajlm-786	77	1	martinez	martinez	PROPN
ajlm-786	77	2	-	-	ADJ
ajlm-786	77	3	quintana	quintana	PROPN
ajlm-786	77	4	e	e	PROPN
ajlm-786	77	5	,	,	PUNCT
ajlm-786	77	6	tugores	tugore	VERB
ajlm-786	77	7	a	a	DET
ajlm-786	77	8	,	,	PUNCT
ajlm-786	77	9	rodriguez	rodriguez	NOUN
ajlm-786	77	10	-	-	PUNCT
ajlm-786	77	11	gonzález	gonzález	PROPN
ajlm-786	77	12	f.	f.	PROPN
ajlm-786	77	13	serum	serum	PROPN
ajlm-786	77	14	uric	uric	ADJ
ajlm-786	77	15	acid	acid	NOUN
ajlm-786	77	16	levels	level	NOUN
ajlm-786	77	17	and	and	CCONJ
ajlm-786	77	18	cardiovascular	cardiovascular	ADJ
ajlm-786	77	19	disease	disease	NOUN
ajlm-786	77	20	:	:	PUNCT
ajlm-786	77	21	the	the	DET
ajlm-786	77	22	gordian	gordian	ADJ
ajlm-786	77	23	knot	knot	NOUN
ajlm-786	77	24	.	.	PUNCT
ajlm-786	78	1	j	j	PROPN
ajlm-786	78	2	thorac	thorac	PROPN
ajlm-786	78	3	.	.	PUNCT
ajlm-786	79	1	2016;8(11):e1462	2016;8(11):e1462	NOUN
ajlm-786	79	2	–	–	PUNCT
ajlm-786	79	3	e1466	e1466	PROPN
ajlm-786	79	4	.	.	PUNCT
ajlm-786	80	1	https://doi.org/10.21037/jtd.2016.11.39	https://doi.org/10.21037/jtd.2016.11.39	PROPN
ajlm-786	80	2	kivity	kivity	PROPN
ajlm-786	80	3	s	s	PROPN
ajlm-786	80	4	,	,	PUNCT
ajlm-786	80	5	kopel	kopel	PROPN
ajlm-786	80	6	e	e	PROPN
ajlm-786	80	7	,	,	PUNCT
ajlm-786	80	8	maor	maor	PROPN
ajlm-786	80	9	e	e	NOUN
ajlm-786	80	10	,	,	PUNCT
ajlm-786	80	11	et	et	PROPN
ajlm-786	80	12	al	al	PROPN
ajlm-786	80	13	.	.	PROPN
ajlm-786	80	14	association	association	PROPN
ajlm-786	80	15	of	of	ADP
ajlm-786	80	16	serum	serum	PROPN
ajlm-786	80	17	uric	uric	ADJ
ajlm-786	80	18	acid	acid	NOUN
ajlm-786	80	19	and	and	CCONJ
ajlm-786	80	20	cardiovascular	cardiovascular	ADJ
ajlm-786	80	21	disease	disease	NOUN
ajlm-786	80	22	in	in	ADP
ajlm-786	80	23	healthy	healthy	ADJ
ajlm-786	80	24	adults	adult	NOUN
ajlm-786	80	25	.	.	PUNCT
ajlm-786	81	1	am	be	AUX
ajlm-786	81	2	j	j	PROPN
ajlm-786	81	3	cardiol	cardiol	NOUN
ajlm-786	81	4	.	.	PUNCT
ajlm-786	82	1	2013;111:1146–1151	2013;111:1146–1151	NUM
ajlm-786	82	2	.	.	NOUN
ajlm-786	82	3	https://doi.org/10.1016/j.amjcard.2012.12.034	https://doi.org/10.1016/j.amjcard.2012.12.034	PROPN
ajlm-786	82	4	ranjith	ranjith	PROPN
ajlm-786	82	5	n	n	CCONJ
ajlm-786	82	6	,	,	PUNCT
ajlm-786	82	7	myeni	myeni	ADJ
ajlm-786	82	8	nn	nn	PROPN
ajlm-786	82	9	,	,	PUNCT
ajlm-786	82	10	sartorius	sartorius	NOUN
ajlm-786	82	11	b	b	PROPN
ajlm-786	82	12	,	,	PUNCT
ajlm-786	82	13	et	et	PROPN
ajlm-786	82	14	al	al	PROPN
ajlm-786	82	15	.	.	PROPN
ajlm-786	82	16	association	association	PROPN
ajlm-786	82	17	between	between	ADP
ajlm-786	82	18	hyperuricemia	hyperuricemia	NOUN
ajlm-786	82	19	and	and	CCONJ
ajlm-786	82	20	major	major	ADJ
ajlm-786	82	21	adverse	adverse	ADJ
ajlm-786	82	22	cardiac	cardiac	ADJ
ajlm-786	82	23	events	event	NOUN
ajlm-786	82	24	in	in	ADP
ajlm-786	82	25	patients	patient	NOUN
ajlm-786	82	26	with	with	ADP
ajlm-786	82	27	acute	acute	ADJ
ajlm-786	82	28	myocardial	myocardial	ADJ
ajlm-786	82	29	infarction	infarction	NOUN
ajlm-786	82	30	.	.	PUNCT
ajlm-786	83	1	metab	metab	ADJ
ajlm-786	83	2	syndr	syndr	PROPN
ajlm-786	83	3	relat	relat	PROPN
ajlm-786	83	4	disord	disord	NOUN
ajlm-786	83	5	.	.	PUNCT
ajlm-786	84	1	2017	2017	NUM
ajlm-786	84	2	;	;	PUNCT
ajlm-786	84	3	15:18–25	15:18–25	NUM
ajlm-786	84	4	.	.	PUNCT
ajlm-786	85	1	https://doi.org/10.1089/met.2016.0032	https://doi.org/10.1089/met.2016.0032	PROPN
ajlm-786	85	2	baker	baker	PROPN
ajlm-786	85	3	jf	jf	PROPN
ajlm-786	85	4	,	,	PUNCT
ajlm-786	85	5	krishnan	krishnan	PROPN
ajlm-786	85	6	e	e	PROPN
ajlm-786	85	7	,	,	PUNCT
ajlm-786	85	8	chen	chen	PROPN
ajlm-786	85	9	l	l	PROPN
ajlm-786	85	10	,	,	PUNCT
ajlm-786	85	11	et	et	PROPN
ajlm-786	85	12	al	al	PROPN
ajlm-786	85	13	.	.	PROPN
ajlm-786	85	14	serum	serum	PROPN
ajlm-786	85	15	uric	uric	ADJ
ajlm-786	85	16	acid	acid	NOUN
ajlm-786	85	17	and	and	CCONJ
ajlm-786	85	18	cardiovascular	cardiovascular	ADJ
ajlm-786	85	19	disease	disease	NOUN
ajlm-786	85	20	:	:	PUNCT
ajlm-786	85	21	recent	recent	ADJ
ajlm-786	85	22	developments	development	NOUN
ajlm-786	85	23	,	,	PUNCT
ajlm-786	85	24	and	and	CCONJ
ajlm-786	85	25	where	where	SCONJ
ajlm-786	85	26	do	do	AUX
ajlm-786	85	27	they	they	PRON
ajlm-786	85	28	leave	leave	VERB
ajlm-786	85	29	us	we	PRON
ajlm-786	85	30	?	?	PUNCT
ajlm-786	86	1	am	be	AUX
ajlm-786	86	2	j	j	PROPN
ajlm-786	86	3	med	med	PROPN
ajlm-786	86	4	.	.	PUNCT
ajlm-786	87	1	2005;118:816–826	2005;118:816–826	NUM
ajlm-786	87	2	.	.	PUNCT
ajlm-786	88	1	https://doi.org/10.1016/j.amjmed.2005.03.043	https://doi.org/10.1016/j.amjmed.2005.03.043	NOUN
ajlm-786	88	2	heinig	heinig	PROPN
ajlm-786	88	3	m	m	PROPN
ajlm-786	88	4	,	,	PUNCT
ajlm-786	88	5	johnson	johnson	PROPN
ajlm-786	88	6	rj	rj	PROPN
ajlm-786	88	7	.	.	PUNCT
ajlm-786	88	8	role	role	NOUN
ajlm-786	88	9	of	of	ADP
ajlm-786	88	10	uric	uric	ADJ
ajlm-786	88	11	acid	acid	NOUN
ajlm-786	88	12	in	in	ADP
ajlm-786	88	13	hypertension	hypertension	NOUN
ajlm-786	88	14	,	,	PUNCT
ajlm-786	88	15	renal	renal	ADJ
ajlm-786	88	16	disease	disease	NOUN
ajlm-786	88	17	,	,	PUNCT
ajlm-786	88	18	and	and	CCONJ
ajlm-786	88	19	metabolic	metabolic	NOUN
ajlm-786	88	20	syndrome	syndrome	NOUN
ajlm-786	88	21	.	.	PUNCT
ajlm-786	89	1	cleve	cleve	PROPN
ajlm-786	89	2	clin	clin	PROPN
ajlm-786	89	3	j	j	PROPN
ajlm-786	89	4	med	med	PROPN
ajlm-786	89	5	.	.	PUNCT
ajlm-786	90	1	2006;73:1059–1064	2006;73:1059–1064	NOUN
ajlm-786	90	2	.	.	PUNCT
ajlm-786	91	1	lv	lv	PROPN
ajlm-786	91	2	q	q	PROPN
ajlm-786	91	3	,	,	PUNCT
ajlm-786	91	4	meng	meng	PROPN
ajlm-786	91	5	xf	xf	PROPN
ajlm-786	91	6	,	,	PUNCT
ajlm-786	91	7	he	he	PRON
ajlm-786	91	8	ff	ff	VERB
ajlm-786	91	9	,	,	PUNCT
ajlm-786	91	10	et	et	PROPN
ajlm-786	91	11	al	al	PROPN
ajlm-786	91	12	.	.	PROPN
ajlm-786	92	1	high	high	PROPN
ajlm-786	92	2	serum	serum	PROPN
ajlm-786	92	3	uric	uric	ADJ
ajlm-786	92	4	acid	acid	NOUN
ajlm-786	92	5	and	and	CCONJ
ajlm-786	92	6	increased	increase	VERB
ajlm-786	92	7	risk	risk	NOUN
ajlm-786	92	8	of	of	ADP
ajlm-786	92	9	type	type	NOUN
ajlm-786	92	10	2	2	NUM
ajlm-786	92	11	diabetes	diabetes	NOUN
ajlm-786	92	12	:	:	PUNCT
ajlm-786	92	13	a	a	DET
ajlm-786	92	14	systematic	systematic	ADJ
ajlm-786	92	15	review	review	NOUN
ajlm-786	92	16	and	and	CCONJ
ajlm-786	92	17	meta	meta	ADJ
ajlm-786	92	18	-	-	PUNCT
ajlm-786	92	19	analysis	analysis	NOUN
ajlm-786	92	20	of	of	ADP
ajlm-786	92	21	prospective	prospective	ADJ
ajlm-786	92	22	cohort	cohort	NOUN
ajlm-786	92	23	studies	study	NOUN
ajlm-786	92	24	.	.	PUNCT
ajlm-786	93	1	plos	plos	PROPN
ajlm-786	93	2	one	one	NUM
ajlm-786	93	3	.	.	PUNCT
ajlm-786	94	1	2013;8(2):e56864	2013;8(2):e56864	NUM
ajlm-786	94	2	.	.	PUNCT
ajlm-786	95	1	https://doi.org/10.1371/journal.pone.0056864	https://doi.org/10.1371/journal.pone.0056864	PROPN
ajlm-786	95	2	kodam	kodam	PROPN
ajlm-786	95	3	s	s	PROPN
ajlm-786	95	4	,	,	PUNCT
ajlm-786	95	5	saito	saito	PROPN
ajlm-786	95	6	k	k	PROPN
ajlm-786	95	7	,	,	PUNCT
ajlm-786	95	8	yachi	yachi	PROPN
ajlm-786	95	9	y	y	PROPN
ajlm-786	95	10	,	,	PUNCT
ajlm-786	95	11	et	et	PROPN
ajlm-786	95	12	al	al	PROPN
ajlm-786	95	13	.	.	PROPN
ajlm-786	95	14	association	association	PROPN
ajlm-786	95	15	between	between	ADP
ajlm-786	95	16	serum	serum	PROPN
ajlm-786	95	17	uric	uric	ADJ
ajlm-786	95	18	acid	acid	NOUN
ajlm-786	95	19	and	and	CCONJ
ajlm-786	95	20	development	development	NOUN
ajlm-786	95	21	of	of	ADP
ajlm-786	95	22	type	type	NOUN
ajlm-786	95	23	2	2	NUM
ajlm-786	95	24	diabetes	diabetes	NOUN
ajlm-786	95	25	.	.	PUNCT
ajlm-786	96	1	diabetes	diabetes	NOUN
ajlm-786	96	2	care	care	VERB
ajlm-786	96	3	.	.	PUNCT
ajlm-786	97	1	2009;32:1737–1742	2009;32:1737–1742	X
ajlm-786	97	2	.	.	PUNCT
ajlm-786	98	1	https://doi.org/10.2337/dc09-0288	https://doi.org/10.2337/dc09-0288	PROPN
ajlm-786	98	2	jia	jia	PROPN
ajlm-786	99	1	z	z	PROPN
ajlm-786	99	2	,	,	PUNCT
ajlm-786	99	3	zhang	zhang	PROPN
ajlm-786	99	4	x	x	PROPN
ajlm-786	99	5	,	,	PUNCT
ajlm-786	99	6	kang	kang	PROPN
ajlm-786	99	7	s	s	PROPN
ajlm-786	99	8	,	,	PUNCT
ajlm-786	99	9	et	et	PROPN
ajlm-786	99	10	al	al	PROPN
ajlm-786	99	11	.	.	PROPN
ajlm-786	99	12	serum	serum	PROPN
ajlm-786	99	13	uric	uric	ADJ
ajlm-786	99	14	acid	acid	NOUN
ajlm-786	99	15	levels	level	NOUN
ajlm-786	99	16	and	and	CCONJ
ajlm-786	99	17	incidence	incidence	NOUN
ajlm-786	99	18	of	of	ADP
ajlm-786	99	19	impaired	impaired	ADJ
ajlm-786	99	20	fasting	fasting	NOUN
ajlm-786	99	21	glucose	glucose	NOUN
ajlm-786	99	22	and	and	CCONJ
ajlm-786	99	23	type	type	NOUN
ajlm-786	99	24	2	2	NUM
ajlm-786	99	25	diabetes	diabetes	NOUN
ajlm-786	99	26	mellitus	mellitus	NOUN
ajlm-786	99	27	:	:	PUNCT
ajlm-786	99	28	a	a	DET
ajlm-786	99	29	meta	meta	ADJ
ajlm-786	99	30	-	-	PUNCT
ajlm-786	99	31	analysis	analysis	NOUN
ajlm-786	99	32	of	of	ADP
ajlm-786	99	33	cohort	cohort	NOUN
ajlm-786	99	34	studies	study	NOUN
ajlm-786	99	35	.	.	PUNCT
ajlm-786	100	1	diabetes	diabetes	NOUN
ajlm-786	100	2	res	re	VERB
ajlm-786	100	3	clin	clin	PROPN
ajlm-786	100	4	pract	pract	PROPN
ajlm-786	100	5	.	.	PUNCT
ajlm-786	101	1	2013;101:88–96	2013;101:88–96	NUM
ajlm-786	101	2	.	.	PUNCT
ajlm-786	102	1	https://doi.org/10.1016/j.diabres.2013.03.026	https://doi.org/10.1016/j.diabres.2013.03.026	PROPN
ajlm-786	102	2	lee	lee	PROPN
ajlm-786	102	3	jj	jj	PROPN
ajlm-786	102	4	,	,	PUNCT
ajlm-786	102	5	yang	yang	PROPN
ajlm-786	102	6	ih	ih	PROPN
ajlm-786	102	7	,	,	PUNCT
ajlm-786	102	8	kuo	kuo	PROPN
ajlm-786	102	9	hk	hk	PROPN
ajlm-786	102	10	,	,	PUNCT
ajlm-786	102	11	et	et	PROPN
ajlm-786	102	12	al	al	PROPN
ajlm-786	102	13	.	.	PROPN
ajlm-786	102	14	serum	serum	PROPN
ajlm-786	102	15	uric	uric	PROPN
ajlm-786	102	16	acid	acid	PROPN
ajlm-786	102	17	concebtration	concebtration	NOUN
ajlm-786	102	18	is	be	AUX
ajlm-786	102	19	associated	associate	VERB
ajlm-786	102	20	with	with	ADP
ajlm-786	102	21	worsening	worsen	VERB
ajlm-786	102	22	in	in	ADP
ajlm-786	102	23	severity	severity	NOUN
ajlm-786	102	24	of	of	ADP
ajlm-786	102	25	diabetic	diabetic	ADJ
ajlm-786	102	26	nephropathy	nephropathy	NOUN
ajlm-786	102	27	among	among	ADP
ajlm-786	102	28	type	type	NOUN
ajlm-786	102	29	2	2	NUM
ajlm-786	102	30	diabetic	diabetic	ADJ
ajlm-786	102	31	patients	patient	NOUN
ajlm-786	102	32	in	in	ADP
ajlm-786	102	33	taiwan	taiwan	PROPN
ajlm-786	102	34	–	–	PUNCT
ajlm-786	102	35	a	a	DET
ajlm-786	102	36	3	3	NUM
ajlm-786	102	37	-	-	PUNCT
ajlm-786	102	38	year	year	NOUN
ajlm-786	102	39	prospective	prospective	ADJ
ajlm-786	102	40	study	study	NOUN
ajlm-786	102	41	.	.	PUNCT
ajlm-786	103	1	diabetes	diabetes	NOUN
ajlm-786	103	2	res	re	VERB
ajlm-786	103	3	clin	clin	PROPN
ajlm-786	103	4	pract	pract	PROPN
ajlm-786	103	5	.	.	PUNCT
ajlm-786	104	1	2014;106	2014;106	NUM
ajlm-786	104	2	(	(	PUNCT
ajlm-786	104	3	2):366–372	2):366–372	NUM
ajlm-786	104	4	.	.	PUNCT
ajlm-786	105	1	https://doi.org/10.1016/j.diabres.2014.07.027	https://doi.org/10.1016/j.diabres.2014.07.027	NUM
ajlm-786	105	2	klein	klein	PROPN
ajlm-786	105	3	r	r	PROPN
ajlm-786	105	4	,	,	PUNCT
ajlm-786	105	5	klein	klein	PROPN
ajlm-786	105	6	be	be	VERB
ajlm-786	105	7	,	,	PUNCT
ajlm-786	105	8	moss	moss	PROPN
ajlm-786	105	9	se	se	X
ajlm-786	105	10	.	.	PUNCT
ajlm-786	106	1	relation	relation	NOUN
ajlm-786	106	2	of	of	ADP
ajlm-786	106	3	glycemic	glycemic	ADJ
ajlm-786	106	4	control	control	NOUN
ajlm-786	106	5	to	to	ADP
ajlm-786	106	6	diabetic	diabetic	ADJ
ajlm-786	106	7	microvascular	microvascular	ADJ
ajlm-786	106	8	complications	complication	NOUN
ajlm-786	106	9	in	in	ADP
ajlm-786	106	10	diabetes	diabetes	NOUN
ajlm-786	106	11	mellitus	mellitus	NOUN
ajlm-786	106	12	.	.	PUNCT
ajlm-786	107	1	ann	ann	PROPN
ajlm-786	107	2	intern	intern	PROPN
ajlm-786	107	3	med	me	VERB
ajlm-786	107	4	.	.	PUNCT
ajlm-786	108	1	1996;124:90–96	1996;124:90–96	NUM
ajlm-786	108	2	.	.	PUNCT
ajlm-786	109	1	https://doi.org/10.7326/0003-4819-124-1_part_2-199601011-00003	https://doi.org/10.7326/0003-4819-124-1_part_2-199601011-00003	ADP
ajlm-786	109	2	nih	nih	PROPN
ajlm-786	109	3	consensus	consensus	PROPN
ajlm-786	109	4	conference	conference	NOUN
ajlm-786	109	5	:	:	PUNCT
ajlm-786	109	6	triglyceride	triglyceride	ADJ
ajlm-786	109	7	,	,	PUNCT
ajlm-786	109	8	high	high	ADJ
ajlm-786	109	9	-	-	PUNCT
ajlm-786	109	10	density	density	NOUN
ajlm-786	109	11	lipoprotein	lipoprotein	ADJ
ajlm-786	109	12	and	and	CCONJ
ajlm-786	109	13	coronary	coronary	ADJ
ajlm-786	109	14	heart	heart	NOUN
ajlm-786	109	15	disease	disease	NOUN
ajlm-786	109	16	.	.	PUNCT
ajlm-786	110	1	jama	jama	PROPN
ajlm-786	110	2	.	.	PUNCT
ajlm-786	111	1	1993;269:505–510	1993;269:505–510	X
ajlm-786	111	2	.	.	PUNCT
ajlm-786	112	1	bowers	bowers	PROPN
ajlm-786	112	2	ld	ld	PROPN
ajlm-786	112	3	,	,	PUNCT
ajlm-786	112	4	wong	wong	PROPN
ajlm-786	112	5	et	et	PROPN
ajlm-786	112	6	.	.	PUNCT
ajlm-786	113	1	kinetic	kinetic	ADJ
ajlm-786	113	2	serum	serum	NOUN
ajlm-786	113	3	creatinine	creatinine	NOUN
ajlm-786	113	4	assays	assay	NOUN
ajlm-786	113	5	.	.	PUNCT
ajlm-786	114	1	ii	ii	X
ajlm-786	114	2	.	.	PUNCT
ajlm-786	115	1	a	a	DET
ajlm-786	115	2	critical	critical	ADJ
ajlm-786	115	3	evaluation	evaluation	NOUN
ajlm-786	115	4	and	and	CCONJ
ajlm-786	115	5	review	review	NOUN
ajlm-786	115	6	.	.	PUNCT
ajlm-786	116	1	clin	clin	PROPN
ajlm-786	116	2	chem	chem	PROPN
ajlm-786	116	3	.	.	PUNCT
ajlm-786	117	1	1980;26	1980;26	NUM
ajlm-786	117	2	(	(	PUNCT
ajlm-786	117	3	5):555–561	5):555–561	NUM
ajlm-786	117	4	.	.	PUNCT
ajlm-786	118	1	fouad	fouad	PROPN
ajlm-786	118	2	m	m	PROPN
ajlm-786	118	3	,	,	PUNCT
ajlm-786	118	4	fathy	fathy	PROPN
ajlm-786	118	5	h	h	PROPN
ajlm-786	118	6	,	,	PUNCT
ajlm-786	118	7	zidan	zidan	PROPN
ajlm-786	118	8	a.	a.	PROPN
ajlm-786	118	9	serum	serum	PROPN
ajlm-786	118	10	uric	uric	PROPN
ajlm-786	118	11	acid	acid	PROPN
ajlm-786	118	12	and	and	CCONJ
ajlm-786	118	13	its	its	PRON
ajlm-786	118	14	association	association	NOUN
ajlm-786	118	15	with	with	ADP
ajlm-786	118	16	hypertension	hypertension	NOUN
ajlm-786	118	17	,	,	PUNCT
ajlm-786	118	18	early	early	ADJ
ajlm-786	118	19	nephropathy	nephropathy	NOUN
ajlm-786	118	20	and	and	CCONJ
ajlm-786	118	21	chronic	chronic	ADJ
ajlm-786	118	22	kidney	kidney	NOUN
ajlm-786	118	23	disease	disease	NOUN
ajlm-786	118	24	in	in	ADP
ajlm-786	118	25	type	type	NOUN
ajlm-786	118	26	2	2	NUM
ajlm-786	118	27	diabetic	diabetic	ADJ
ajlm-786	118	28	patients	patient	NOUN
ajlm-786	118	29	.	.	PUNCT
ajlm-786	119	1	j	j	PROPN
ajlm-786	119	2	bras	bras	PROPN
ajlm-786	119	3	nefrol	nefrol	NOUN
ajlm-786	119	4	.	.	PUNCT
ajlm-786	120	1	2016;38:403–410	2016;38:403–410	NOUN
ajlm-786	120	2	.	.	PUNCT
ajlm-786	121	1	https://doi.org/10.5935/0101-2800.20160065	https://doi.org/10.5935/0101-2800.20160065	PROPN
ajlm-786	121	2	bandaru	bandaru	NOUN
ajlm-786	121	3	p	p	NOUN
ajlm-786	121	4	,	,	PUNCT
ajlm-786	121	5	shankar	shankar	PROPN
ajlm-786	121	6	a.	a.	PROPN
ajlm-786	121	7	association	association	PROPN
ajlm-786	121	8	between	between	ADP
ajlm-786	121	9	serum	serum	PROPN
ajlm-786	121	10	uric	uric	ADJ
ajlm-786	121	11	acid	acid	NOUN
ajlm-786	121	12	levels	level	NOUN
ajlm-786	121	13	and	and	CCONJ
ajlm-786	121	14	diabetes	diabetes	NOUN
ajlm-786	121	15	mellitus	mellitus	NOUN
ajlm-786	121	16	.	.	PUNCT
ajlm-786	122	1	int	int	PROPN
ajlm-786	122	2	j	j	PROPN
ajlm-786	122	3	endocrinol	endocrinol	NOUN
ajlm-786	122	4	.	.	PUNCT
ajlm-786	123	1	2011;604–715	2011;604–715	NUM
ajlm-786	123	2	.	.	PUNCT
ajlm-786	124	1	https://doi.org/10.1155/2011/604715	https://doi.org/10.1155/2011/604715	NOUN
ajlm-786	124	2	cui	cui	NOUN
ajlm-786	124	3	y	y	PROPN
ajlm-786	124	4	,	,	PUNCT
ajlm-786	124	5	bu	bu	PROPN
ajlm-786	124	6	h	h	PROPN
ajlm-786	124	7	,	,	PUNCT
ajlm-786	124	8	ma	ma	PROPN
ajlm-786	124	9	x	x	PROPN
ajlm-786	124	10	,	,	PUNCT
ajlm-786	124	11	et	et	PROPN
ajlm-786	124	12	al	al	PROPN
ajlm-786	124	13	.	.	PUNCT
ajlm-786	125	1	the	the	DET
ajlm-786	125	2	relation	relation	NOUN
ajlm-786	125	3	between	between	ADP
ajlm-786	125	4	serum	serum	NOUN
ajlm-786	125	5	uric	uric	ADJ
ajlm-786	125	6	acid	acid	NOUN
ajlm-786	125	7	and	and	CCONJ
ajlm-786	125	8	hba1c	hba1c	PROPN
ajlm-786	125	9	is	be	AUX
ajlm-786	125	10	dependent	dependent	ADJ
ajlm-786	125	11	upon	upon	SCONJ
ajlm-786	125	12	hyperinsulinemia	hyperinsulinemia	NOUN
ajlm-786	125	13	in	in	ADP
ajlm-786	125	14	patients	patient	NOUN
ajlm-786	125	15	with	with	ADP
ajlm-786	125	16	newly	newly	ADV
ajlm-786	125	17	diagnosed	diagnose	VERB
ajlm-786	125	18	type	type	NOUN
ajlm-786	125	19	2	2	NUM
ajlm-786	125	20	diabetes	diabetes	NOUN
ajlm-786	125	21	mellitus	mellitus	NOUN
ajlm-786	125	22	.	.	PUNCT
ajlm-786	126	1	j	j	PROPN
ajlm-786	126	2	diabetes	diabetes	NOUN
ajlm-786	126	3	res	re	NOUN
ajlm-786	126	4	.	.	PUNCT
ajlm-786	127	1	2016:7184123	2016:7184123	NUM
ajlm-786	127	2	.	.	PUNCT
ajlm-786	127	3	https://doi.org/10.1155/2016/7184123	https://doi.org/10.1155/2016/7184123	VERB
ajlm-786	127	4	da	da	PROPN
ajlm-786	127	5	luz	luz	PROPN
ajlm-786	127	6	pl	pl	PROPN
ajlm-786	127	7	,	,	PUNCT
ajlm-786	127	8	favarato	favarato	NOUN
ajlm-786	127	9	d	d	PROPN
ajlm-786	127	10	,	,	PUNCT
ajlm-786	127	11	faria	faria	PROPN
ajlm-786	127	12	-	-	PUNCT
ajlm-786	127	13	neto	neto	PROPN
ajlm-786	127	14	jr	jr	PROPN
ajlm-786	127	15	jr	jr	PROPN
ajlm-786	127	16	,	,	PUNCT
ajlm-786	127	17	et	et	PROPN
ajlm-786	127	18	al	al	PROPN
ajlm-786	127	19	.	.	PROPN
ajlm-786	128	1	high	high	ADJ
ajlm-786	128	2	ratio	ratio	NOUN
ajlm-786	128	3	of	of	ADP
ajlm-786	128	4	triglycerides	triglyceride	NOUN
ajlm-786	128	5	to	to	ADP
ajlm-786	128	6	hdl	hdl	NOUN
ajlm-786	128	7	-	-	PUNCT
ajlm-786	128	8	cholesterol	cholesterol	NOUN
ajlm-786	128	9	ratio	ratio	NOUN
ajlm-786	128	10	predicts	predict	VERB
ajlm-786	128	11	extensive	extensive	ADJ
ajlm-786	128	12	coronary	coronary	ADJ
ajlm-786	128	13	disease	disease	NOUN
ajlm-786	128	14	.	.	PUNCT
ajlm-786	129	1	clinics	clinic	NOUN
ajlm-786	129	2	.	.	PUNCT
ajlm-786	130	1	2008;63:427–432	2008;63:427–432	NOUN
ajlm-786	130	2	.	.	PUNCT
ajlm-786	131	1	https://doi.org/10.1590/s1807-59322008000400003	https://doi.org/10.1590/s1807-59322008000400003	PROPN
ajlm-786	131	2	gaziano	gaziano	PROPN
ajlm-786	131	3	jm	jm	PROPN
ajlm-786	131	4	,	,	PUNCT
ajlm-786	131	5	hennekens	hennekens	PROPN
ajlm-786	131	6	ch	ch	PROPN
ajlm-786	131	7	,	,	PUNCT
ajlm-786	131	8	o’donnell	o’donnell	PROPN
ajlm-786	131	9	cj	cj	NUM
ajlm-786	131	10	,	,	PUNCT
ajlm-786	131	11	et	et	PROPN
ajlm-786	131	12	al	al	PROPN
ajlm-786	131	13	.	.	PUNCT
ajlm-786	132	1	fasting	fast	VERB
ajlm-786	132	2	triglycerides	triglyceride	NOUN
ajlm-786	132	3	,	,	PUNCT
ajlm-786	132	4	high	high	ADJ
ajlm-786	132	5	density	density	NOUN
ajlm-786	132	6	lipoprotein	lipoprotein	ADJ
ajlm-786	132	7	,	,	PUNCT
ajlm-786	132	8	and	and	CCONJ
ajlm-786	132	9	risk	risk	NOUN
ajlm-786	132	10	of	of	ADP
ajlm-786	132	11	myocardial	myocardial	ADJ
ajlm-786	132	12	infarction	infarction	NOUN
ajlm-786	132	13	.	.	PUNCT
ajlm-786	133	1	circulation	circulation	NOUN
ajlm-786	133	2	.	.	PUNCT
ajlm-786	134	1	1997	1997	NUM
ajlm-786	134	2	;	;	PUNCT
ajlm-786	135	1	96:2520–2525	96:2520–2525	NUM
ajlm-786	135	2	.	.	PUNCT
ajlm-786	136	1	https://doi.org/10.1161/01.cir.96.8.2520	https://doi.org/10.1161/01.cir.96.8.2520	PROPN
ajlm-786	136	2	hadaeghi	hadaeghi	PROPN
ajlm-786	136	3	f	f	PROPN
ajlm-786	136	4	,	,	PUNCT
ajlm-786	136	5	khalili	khalili	PROPN
ajlm-786	136	6	d	d	PROPN
ajlm-786	136	7	,	,	PUNCT
ajlm-786	136	8	ghasemi	ghasemi	PROPN
ajlm-786	136	9	a	a	X
ajlm-786	136	10	,	,	PUNCT
ajlm-786	136	11	et	et	PROPN
ajlm-786	136	12	al	al	PROPN
ajlm-786	136	13	.	.	PUNCT
ajlm-786	136	14	triglyceride	triglyceride	PROPN
ajlm-786	136	15	/	/	SYM
ajlm-786	136	16	hdl	hdl	NOUN
ajlm-786	136	17	-	-	PUNCT
ajlm-786	136	18	cholesterol	cholesterol	NOUN
ajlm-786	136	19	ratio	ratio	NOUN
ajlm-786	136	20	is	be	AUX
ajlm-786	136	21	an	an	DET
ajlm-786	136	22	independent	independent	ADJ
ajlm-786	136	23	predictor	predictor	NOUN
ajlm-786	136	24	for	for	ADP
ajlm-786	136	25	coronary	coronary	ADJ
ajlm-786	136	26	heart	heart	NOUN
ajlm-786	136	27	disease	disease	NOUN
ajlm-786	136	28	in	in	ADP
ajlm-786	136	29	a	a	DET
ajlm-786	136	30	population	population	NOUN
ajlm-786	136	31	of	of	ADP
ajlm-786	136	32	iranian	iranian	ADJ
ajlm-786	136	33	men	man	NOUN
ajlm-786	136	34	.	.	PUNCT
ajlm-786	137	1	nutr	nutr	PROPN
ajlm-786	137	2	metab	metab	PROPN
ajlm-786	137	3	cardiovsac	cardiovsac	PROPN
ajlm-786	137	4	dis	dis	PROPN
ajlm-786	137	5	.	.	PUNCT
ajlm-786	138	1	2009;19(6):401–408	2009;19(6):401–408	X
ajlm-786	138	2	.	.	X
ajlm-786	138	3	https://doi.org/10.1016/j.numecd.2008.09.003	https://doi.org/10.1016/j.numecd.2008.09.003	PROPN
ajlm-786	138	4	sumner	sumner	PROPN
ajlm-786	138	5	ae	ae	PROPN
ajlm-786	138	6	,	,	PUNCT
ajlm-786	138	7	finley	finley	PROPN
ajlm-786	138	8	kb	kb	PROPN
ajlm-786	138	9	,	,	PUNCT
ajlm-786	138	10	genovese	genovese	NOUN
ajlm-786	138	11	dj	dj	PROPN
ajlm-786	138	12	,	,	PUNCT
ajlm-786	138	13	et	et	PROPN
ajlm-786	138	14	al	al	PROPN
ajlm-786	138	15	.	.	PUNCT
ajlm-786	139	1	fasting	fast	VERB
ajlm-786	139	2	triglyceride	triglyceride	ADV
ajlm-786	139	3	and	and	CCONJ
ajlm-786	139	4	the	the	DET
ajlm-786	139	5	triglyceride	triglyceride	ADJ
ajlm-786	139	6	-	-	PUNCT
ajlm-786	139	7	hdl	hdl	NOUN
ajlm-786	139	8	cholesterol	cholesterol	NOUN
ajlm-786	139	9	ratio	ratio	NOUN
ajlm-786	139	10	are	be	AUX
ajlm-786	139	11	not	not	PART
ajlm-786	139	12	markers	marker	NOUN
ajlm-786	139	13	of	of	ADP
ajlm-786	139	14	insulin	insulin	NOUN
ajlm-786	139	15	resistance	resistance	NOUN
ajlm-786	139	16	in	in	ADP
ajlm-786	139	17	african	african	ADJ
ajlm-786	139	18	americans	americans	PROPN
ajlm-786	139	19	.	.	PUNCT
ajlm-786	140	1	arch	arch	ADJ
ajlm-786	140	2	intern	intern	NOUN
ajlm-786	140	3	med	med	PROPN
ajlm-786	140	4	.	.	PUNCT
ajlm-786	140	5	2005;165(12):1395–1400	2005;165(12):1395–1400	NUM
ajlm-786	140	6	.	.	PUNCT
ajlm-786	141	1	https://doi.org/10.1001/archinte.165.12.1395	https://doi.org/10.1001/archinte.165.12.1395	PROPN
ajlm-786	141	2	toda	toda	VERB
ajlm-786	141	3	a	a	PRON
ajlm-786	141	4	,	,	PUNCT
ajlm-786	141	5	ishizaka	ishizaka	ADV
ajlm-786	141	6	y	y	NOUN
ajlm-786	141	7	,	,	PUNCT
ajlm-786	141	8	tani	tani	PROPN
ajlm-786	141	9	m	m	PROPN
ajlm-786	141	10	,	,	PUNCT
ajlm-786	141	11	et	et	PROPN
ajlm-786	141	12	al	al	PROPN
ajlm-786	141	13	.	.	PUNCT
ajlm-786	142	1	hyperuricemia	hyperuricemia	PROPN
ajlm-786	142	2	is	be	AUX
ajlm-786	142	3	a	a	DET
ajlm-786	142	4	significant	significant	ADJ
ajlm-786	142	5	risk	risk	NOUN
ajlm-786	142	6	factor	factor	NOUN
ajlm-786	142	7	for	for	ADP
ajlm-786	142	8	the	the	DET
ajlm-786	142	9	onset	onset	NOUN
ajlm-786	142	10	of	of	ADP
ajlm-786	142	11	chronic	chronic	ADJ
ajlm-786	142	12	kidney	kidney	NOUN
ajlm-786	142	13	disease	disease	NOUN
ajlm-786	142	14	.	.	PUNCT
ajlm-786	143	1	nephron	nephron	PROPN
ajlm-786	143	2	clin	clin	PROPN
ajlm-786	143	3	pract	pract	PROPN
ajlm-786	143	4	.	.	PUNCT
ajlm-786	144	1	2014;126(1):33–38	2014;126(1):33–38	X
ajlm-786	144	2	.	.	PUNCT
ajlm-786	144	3	https://doi.org/10.1159/000355639	https://doi.org/10.1159/000355639	PROPN
ajlm-786	144	4	kuwabara	kuwabara	PROPN
ajlm-786	144	5	m	m	PROPN
ajlm-786	144	6	,	,	PUNCT
ajlm-786	144	7	bjornstad	bjornstad	PROPN
ajlm-786	144	8	p	p	NOUN
ajlm-786	144	9	,	,	PUNCT
ajlm-786	144	10	hisatome	hisatome	VERB
ajlm-786	144	11	i	i	PRON
ajlm-786	144	12	,	,	PUNCT
ajlm-786	144	13	et	et	PROPN
ajlm-786	144	14	al	al	PROPN
ajlm-786	144	15	.	.	PROPN
ajlm-786	145	1	elevated	elevated	PROPN
ajlm-786	145	2	serum	serum	PROPN
ajlm-786	145	3	uric	uric	ADJ
ajlm-786	145	4	acid	acid	NOUN
ajlm-786	145	5	level	level	NOUN
ajlm-786	145	6	predicts	predict	VERB
ajlm-786	145	7	rapid	rapid	ADJ
ajlm-786	145	8	decline	decline	NOUN
ajlm-786	145	9	in	in	ADP
ajlm-786	145	10	kidney	kidney	NOUN
ajlm-786	145	11	function	function	NOUN
ajlm-786	145	12	.	.	PUNCT
ajlm-786	146	1	am	be	AUX
ajlm-786	146	2	j	j	NOUN
ajlm-786	146	3	nephrol	nephrol	NOUN
ajlm-786	146	4	.	.	PUNCT
ajlm-786	147	1	2017;45:330–337	2017;45:330–337	NOUN
ajlm-786	147	2	.	.	PUNCT
ajlm-786	148	1	https://doi.org/10.1159/000464260	https://doi.org/10.1159/000464260	PROPN
ajlm-786	148	2	kuwata	kuwata	PROPN
ajlm-786	148	3	h	h	PROPN
ajlm-786	148	4	,	,	PUNCT
ajlm-786	148	5	okamura	okamura	PRON
ajlm-786	148	6	s	s	PROPN
ajlm-786	148	7	,	,	PUNCT
ajlm-786	148	8	hayashino	hayashino	PROPN
ajlm-786	148	9	y	y	PROPN
ajlm-786	148	10	,	,	PUNCT
ajlm-786	148	11	et	et	PROPN
ajlm-786	148	12	al	al	PROPN
ajlm-786	148	13	.	.	PROPN
ajlm-786	148	14	serum	serum	PROPN
ajlm-786	148	15	uric	uric	ADJ
ajlm-786	148	16	acid	acid	PROPN
ajlm-786	148	17	levels	level	NOUN
ajlm-786	148	18	are	be	AUX
ajlm-786	148	19	associated	associate	VERB
ajlm-786	148	20	with	with	ADP
ajlm-786	148	21	increased	increase	VERB
ajlm-786	148	22	risk	risk	NOUN
ajlm-786	148	23	of	of	ADP
ajlm-786	148	24	newly	newly	ADV
ajlm-786	148	25	developed	develop	VERB
ajlm-786	148	26	diabetic	diabetic	ADJ
ajlm-786	148	27	retinopathy	retinopathy	NOUN
ajlm-786	148	28	among	among	ADP
ajlm-786	148	29	japanese	japanese	ADJ
ajlm-786	148	30	male	male	ADJ
ajlm-786	148	31	patients	patient	NOUN
ajlm-786	148	32	with	with	ADP
ajlm-786	148	33	type	type	NOUN
ajlm-786	148	34	2	2	NUM
ajlm-786	148	35	diabetes	diabete	NOUN
ajlm-786	148	36	:	:	PUNCT
ajlm-786	148	37	a	a	DET
ajlm-786	148	38	prospective	prospective	ADJ
ajlm-786	148	39	cohort	cohort	NOUN
ajlm-786	148	40	study	study	NOUN
ajlm-786	148	41	(	(	PUNCT
ajlm-786	148	42	diabetes	diabetes	NOUN
ajlm-786	148	43	distress	distress	NOUN
ajlm-786	148	44	and	and	CCONJ
ajlm-786	148	45	care	care	VERB
ajlm-786	148	46	registry	registry	NOUN
ajlm-786	148	47	at	at	ADP
ajlm-786	148	48	tenri	tenri	NOUN
ajlm-786	148	49	[	[	X
ajlm-786	148	50	ddcrt	ddcrt	NOUN
ajlm-786	148	51	13	13	NUM
ajlm-786	148	52	]	]	PUNCT
ajlm-786	148	53	)	)	PUNCT
ajlm-786	148	54	.	.	PUNCT
ajlm-786	149	1	diabetes	diabetes	NOUN
ajlm-786	149	2	metab	metab	NOUN
ajlm-786	149	3	res	re	NOUN
ajlm-786	149	4	rev	rev	PROPN
ajlm-786	149	5	.	.	PROPN
ajlm-786	149	6	2017;33(7	2017;33(7	NUM
ajlm-786	149	7	)	)	PUNCT
ajlm-786	149	8	https://doi.org/10.1002/dmrr.2905	https://doi.org/10.1002/dmrr.2905	VERB
ajlm-786	149	9	korpachev	korpachev	VERB
ajlm-786	149	10	vv	vv	PROPN
ajlm-786	149	11	,	,	PUNCT
ajlm-786	149	12	hurina	hurina	PROPN
ajlm-786	149	13	nm	nm	PROPN
ajlm-786	149	14	,	,	PUNCT
ajlm-786	149	15	korpacheva	korpacheva	PROPN
ajlm-786	149	16	ti	ti	PROPN
ajlm-786	149	17	,	,	PUNCT
ajlm-786	149	18	et	et	PROPN
ajlm-786	149	19	al	al	PROPN
ajlm-786	149	20	.	.	PUNCT
ajlm-786	150	1	peculiarities	peculiarity	NOUN
ajlm-786	150	2	of	of	ADP
ajlm-786	150	3	uric	uric	ADJ
ajlm-786	150	4	acid	acid	NOUN
ajlm-786	150	5	balance	balance	NOUN
ajlm-786	150	6	disorders	disorder	NOUN
ajlm-786	150	7	in	in	ADP
ajlm-786	150	8	patients	patient	NOUN
ajlm-786	150	9	with	with	ADP
ajlm-786	150	10	type	type	NOUN
ajlm-786	150	11	2	2	NUM
ajlm-786	150	12	diabetes	diabetes	NOUN
ajlm-786	150	13	and	and	CCONJ
ajlm-786	150	14	metabolic	metabolic	NOUN
ajlm-786	150	15	syndrome	syndrome	NOUN
ajlm-786	150	16	.	.	PUNCT
ajlm-786	151	1	fiziol	fiziol	PROPN
ajlm-786	151	2	zh	zh	PROPN
ajlm-786	151	3	.	.	PROPN
ajlm-786	151	4	2009;55(3):133–140	2009;55(3):133–140	NUM
ajlm-786	151	5	.	.	PUNCT